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 BODY COMPOSITION AND MUSCULAR STRENGTH IN ELITE COMPETITIVE 
ATHLETES AND HEALTHY CONTROLS AGED 65 AND OLDER 
Sarah Elizabeth Hunt, M.S 
University of Pittsburgh, 2007
Purpose:  The purpose of this study is to determine if components of body composition differ 
between elite competitive older athletes and community-dwelling ambulatory controls and to 
examine the relationships between the components of body composition and the relationship 
between the components and strength. 
Methods:  One-hundred Senior Athletes from the 2005 National Senior Games and 86 healthy 
controls participated.  Body composition was measured by dual-energy x-ray absorptiometry 
(DXA).  The DXA scans provided measures of bone mineral density (BMD), bone mass, mineral 
free lean mass percentage (MFLP), and fat mass percentage (FMP) including regional measures 
(trunk, legs and arms) of body composition.  Isometric strength of the quadriceps and hamstrings 
was measured.   
Results:  One factor ANOVAs (α=.05) were performed to assess regional FMP and regional 
MFLP.  Controls had a significantly higher FMP in every body region than athletes.  Athletes 
had a significantly higher MFLP of the arm and leg than controls.  Correlational analyses (α=.05) 
were also performed to examine the relationship between MFLP and strength, MFLP and BMD, 
and FMP and BMD.   Athletes had a stronger correlation between flexion strength values and 
MFLP of the leg and Controls showed a stronger correlation between extension strength values 
and MFLP of the leg.  Significant correlations were found for the relationship between MFLP 
and BMD, with stronger correlations in the athlete group.  Significant correlations between BMD 
and FMP were found in all regions except the trunk for all groups. 
Discussion:  Our predominant findings were that, as expected, all regional measures of body fat 
were higher in control subjects than in athletes.  This study showed that all regional measures of 
lean muscle mass were greater in athletes than in control subjects.  This indicates that physical 
activity may help to prevent the decrements associated with the aging process even well in to the 
7th decade of life.  
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1.0  INTRODUCTION 
It is common knowledge that as we age we start to experience difficulties in performing 
tasks that in our younger years seemed effortless.  Many studies have confirmed what people 
have known for years, the aging process in itself causes a variety of physiological decrements 
including, but not limited, to decreases in muscle mass, bone mass, strength, bone density, and 
cardiovascular function, and increases in visceral fat mass, total body fat, and intramuscular lipid 
accumulation. 234, 286  With this knowledge, several studies have set out to find the role of 
exercise in the prevention of such declines associated with aging.  Many studies have turned to 
the Master Athlete as the ideal model of successful aging due to his or her chronic participation 
in high-intensity exercise.113  Using the Master Athlete as an ideal model helps separate the 
modifiable changes associated with aging from the immutable biologic changes.286 
 
In the aging population, total body composition needs to be examined in order to assess 
health risks.  With aging, total body fat increases as well as the risks associated with such 
gains.23, 24, 27 However, elderly people also have less muscle mass, expanded extracellular fluid 
volumes, and reduced body cell mass compared to younger adults.24, 27  This illustrates the 
importance of both fat and non-fat components in influencing the health of the elderly.   Body 
composition alterations in the elderly are due to a complicated combination of factors, including 
hormonal changes that regulate metabolism, dietary intake, and nutrient absorption.19, 91, 268 
 
With aging, an increase in total and visceral fat mass is often seen.  Along with a decline 
in muscle and bone mass, these changes in fat mass may affect metabolic, cardiovascular, and 
musculoskeletal function negatively even in the absence of overt disease.126, 215  A decrease in 
total fat accumulation and visceral adiposity may be related to an increase in endurance type 
physical activity in women and men.58, 129, 153   
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 The decrements associated with aging often accompany functional loss and frailty in 
older adults. Sarcopenia, the decline in skeletal muscle mass, is considered a major contributing 
factor to the loss of functional independence and frailty in these individuals. 264, 266 Young et al. 
(1984, 1985) showed 25-35% reductions in cross-sectional area of the quadriceps muscle in older 
men and women as compared with young controls.342, 343 The apparent loss of muscle mass and 
strength is strongly associated with aging and may accelerate after 65 years of age.27, 90 
Sarcopenia, however, can be slowed or reversed with high-intensity progressive resistance 
exercise.265  Studies on strength trained Master Athletes have shown significantly greater muscle 
mass, improved architecture, and function when compared with sedentary controls of similar 
age.151, 288-290      
 
Aging is also associated with losses in bone mass and density.286  Although genetics has 
been found to be the primary determinant of bone mass in adults in a twin study by Pocock et 
al.224,  many factors play a role in the attainment of peak bone mass and the rate of loss during 
middle and old age.179  Some of these factors include physical activity, body composition, 
hormonal status, and nutrition.66, 108, 254    Exercise has been positively associated with higher 
bone mineral density in populations ranging from adolescents to elderly females.157, 213, 258 
 
 Exercise seems to play a role in preventing or slowing all of the age-related declines 
mentioned above.  This leads us to question the extent to which we can slow or prevent the 
decrements associated with aging.  In order to answer this question, more research is needed on 
life-long participation in exercise and its effects on age-related declines in muscle mass and 
strength, bone mass and density, and increases in body fat as an ideal model for aging.  It is also 
important to examine the relationship between various body composition measures to determine 
what effect, if any, they have on each other.   
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1.1 STATEMENT OF THE PROBLEM 
With many advances in medicine, humans are living longer than ever before.  Because 
losses of muscle and bone mass, muscle strength, and increases of body fat contribute to the loss 
of independence and induce frailty in many of the nation’s elderly, the quest to find the remedy 
to combat the ills of aging is increasing in importance.  The goal of this study is to examine the 
role of elite competitive exercise into the 7th and 8th decade on the body composition changes and 
strength losses associated with aging. The results of this study should suggest future research 
questions and exercise interventions that will increase the quality of life for the growing elderly 
population.  
1.2 OBJECTIVE OF THE STUDY 
Body composition changes with aging, specifically those related to changes in fat mass, 
fat distribution and muscle mass, are common among the general population, even though body 
weight may remain unchanged. 89  However, few have looked at the effect of elite competitive  
participation in exercise into the 7th and 8th decade on these parameters.  The purpose of this 
study is to determine if various components of body composition differ between elite 
competitive older athletes and community-dwelling ambulatory controls and to examine the 
relationships between the components of body composition and strength.  Specifically, to 
examine the relationship between the muscle mass and strength, regional body fat distribution 
and strength, and regional body fat distribution and muscle mass, bone mineral density and bone 
mass in community-dwelling ambulatory controls and elite competitive older athletes.   
 
 
 16 
1.3 SPECIFIC AIMS AND HYPOTHESES 
 
Specific Aim 1.  To determine the difference in regional adiposity between male and 
female elite competitive athletes age 65 years and older and community-dwelling 
ambulatory controls of the same age. 
 
Hypothesis 1.  It is hypothesized that regional adiposity will differ between elite 
competitive athletes age 65 years and older and community-
dwelling ambulatory controls. 
Hypothesis 1a.  It is hypothesized that female elite competitive athletes aged 65  
years and older will have lower percentage of abdominal, leg and 
arm adiposity than will female community-dwelling ambulatory 
controls. 
Hypothesis 1b.  It is hypothesized that male elite competitive athletes aged 65 
years and older will have lower percentage of abdominal, leg and 
arm adiposity than will male community-dwelling ambulatory 
controls. 
 
Specific Aim 2  To determine the difference between regional mineral free lean mass 
between male and female elite competitive athletes age 65 years and older and 
community-dwelling ambulatory controls of the same age. 
 
Hypothesis 2a  It is hypothesized that mineral free lean mass of the arm and leg will 
be greater in female athletes than in female controls age 65 years and older. 
Hypothesis 2b  It is hypothesized that mineral free lean mass of the arm and leg will 
be greater in male athletes than in male controls age 65 years and older. 
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Specific Aim 3.  To determine the relationship between thigh mineral free lean mass and 
thigh muscle strength in a sample of athletes; in a sample of controls; and in a combined 
sample of athletes and controls.  
 
Hypothesis 3.  It is hypothesized that thigh mineral free lean mass will have 
positive correlation with thigh muscle strength in all samples. 
 
Specific Aim 4.  To determine the relationship between mineral free lean mass of the arm 
and leg and bone mineral density in a sample of athletes; in a sample of controls; and in a 
combined sample of athletes and controls. 
 
Hypothesis 4.  It is hypothesized that regional mineral free lean mass will have a 
positive correlation with bone mineral density in all samples.   
 
 
Specific Aim 5.  To determine the relationship between regional fat mass and bone 
mineral density in a sample of athletes; in a sample of controls; and in a combined sample 
of athletes and controls. 
 
Hypothesis 5a.  It is hypothesized that abdominal fat mass and bone mineral 
density will have a positive correlation in all samples. 
Hypothesis 5b.  It is hypothesized that leg fat mass and bone mineral density will 
have a positive correlation in all samples. 
Hypothesis 5c.  It is hypothesized that arm fat mass and bone mineral density will 
have a positive correlation in all samples. 
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1.4 DELIMITATIONS OF THE STUDY 
Subjects will be included in the study if they meet the following criteria: 
? Free of chronic obstructive pulmonary disease, myocardial infarction, or 
coronary artery disease 
? No history of cerebral vascular accident or a history of transient ischemic 
attacks 
? Free of joint replacements, rheumatoid arthritis, gout, bilateral hip replacement, 
lumbar spine surgery or osteoarthritis severe enough to limit activity 
? Does not use a cane or walker 
? No history of osteoporosis for which the subject has received treatment 
? Does not currently use antidepressant drugs or any drugs that may interfere 
with neurological, musculoskeletal, or cognitive function 
? No history of insulin dependent diabetes mellitus, or neurological or 
rheumatologic disorders that might interfere with sensory input.   
? No recent history of fractures, ligament reconstruction, or sprain within the past 
12 months 
? Free of any other disease, injury, or disorder that may affect strength or balance 
? Individuals who have a life long history of competitive activity defined as 20 
years or longer  
? Subjects who are not on medications that can prevent bone loss (e.g., oral or 
intravenous bisphosphonates, calcitonin, SERMs, and parathyroid hormone) or 
cause bone loss (glucocorticoids for greater than 3 months over the last year, 
certain anticonvulsants, anabolic steroids) 
? Free of diseases known to affect bone mineral metabolism (hyperthyroidism, 
hyperparathyroidism, end stage renal or liver disease) 
? No history of cancer within the past 5 years, though subjects with a more recent 
history of relatively benign skin cancers such as basal cell or squamous cell 
carcinoma are not excluded 
 
 
 19 
1.5 LIMITATIONS OF THE STUDY 
The research study was limited by all of the following: 
1. All subjects for this research were volunteers; no attempt was made to control the 
sample for self-selection. 
2. No attempt was made to control for genetics as a determinant of bone mineral 
density, body composition or body fat distribution. 
3. No attempt was made to control for dietary intake as a factor in body 
composition. 
4. No attempt was made to control for calcium intake. 
5. All subjects entering the study were assumed to comply to the best of their ability 
with the methods of testing. 
6. No attempt was made to control for growth hormone or testosterone use. 
7. Testing took place during two consecutive summer months. 
8. The researcher assumed that all subjects answered questions about participation in 
exercise honestly. 
9. The subjects were not recruited from the same geographical area. 
10. Control subjects could participate in recreational exercise.  However, they were 
not participants of the Senior Olympics. 
1.6 DEFINITION OF TERMS 
Abdominal Adiposity:  Fat (adipose tissue) that is centrally distributed between the thorax and 
pelvis and that induces greater health risk. 
Bone Mineral Density: The mineral content in a given volume of bone, used as a measure of 
bony health and in the diagnosis of osteoporosis. 
DXA:  Dual energy X-ray absorptiometry is a means of measuring bone mineral density (BMD). 
Two X-ray beams with differing energy levels are aimed at the patient's bones. When soft tissue 
absorption is subtracted out, the BMD can be determined from the absorption of each beam by 
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bone. DXA is the most widely used and most thoroughly studied bone density measurement 
technology. 
Fat mass:  The absolute amount or mass of body fat. 
Fat free mass:  The mass of the body that is not fat, including muscle, bone, skin, and organs 
Growth Hormone:  An anabolic agent that stimulates fat metabolism and promotes muscle 
growth and hypertrophy by facilitation of amino acid transport into the cells. 
Kyphosis:  Posterior convex angulation of the spine. 
Muscular strength:  The ability of a muscle to exert force. 
Osteoporosis:  A disease characterized by low bone mineral density and microarchitectural 
deterioration of bone tissue leading to enhanced bone fragility and a consequent in fracture risk. 
Sarcopenia:  The loss of muscle mass associated with aging. 
Torque:  The moment of a force; the measure of a force's tendency to produce torsion and 
rotation about an axis, equal to the vector product of the radius vector from the axis of rotation to 
the point of application of the force and the force vector. 
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2.0  REVIEW OF LITERATURE 
Exercise has been touted as an effective intervention to reduce or prevent a number of 
functional declines associated with aging.1  Exercise has been shown to reduce risk factors 
associated with disease states, improve health status and contribute to an increase in life 
expectancy.1  Exercise is also important in combating the negative effects of age-related 
sarcopenia.113  While the master athlete has been proposed as the ideal model of aging due to 
their chronic participation in high intensity exercise, the influence of chronic exercise on body 
composition, muscle mass, and muscle strength has not been extensively studied.37, 113 
 
In this chapter, components of body composition, total body and regional measures, and 
the effects of exercise on each component will be discussed.  The chapter will also include a 
discussion of muscular strength and how it is affected by exercise.  The methodology, including 
equipment and procedure background, will also be included. 
2.1 BODY COMPOSITION 
Body composition has been shown to change dramatically with increasing age.23, 162, 164, 271  
Aging is associated with an increase in fat mass which is positively correlated with metabolic 
syndrome, which is defined by a cluster of risk factors that include obesity, hypertension, 
hypoglycemia, and dyslipidemia.96  According to several studies, body weight increases until 
approximately 60 years of age, followed by a period of marked decline in weight in more than 60 
percent of the population.36, 43, 259, 282, 333  Longitudinal studies have confirmed that the weight 
gain is characterized by a greater percentage of fat than lean tissue.  The risks associated with 
increases in body fat are more widely recognized.  Aging is also associated with declines in 
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muscle and bone mass, expanded extra cellular fluid volumes, and reduced body cell mass.23 
According to Allen et al. and Pierson et al.,  lean mass peaks in the third and fourth decade of 
life, followed by a steady decline with advancing age.9, 220   The loss of muscle mass is 
associated with weakness, disability, and morbidity.25, 84, 126   
 
Health of the elderly person is best assessed by looking at all components of body 
composition.  This is especially important due to the conflicting literature regarding the sources 
of major disability.  Frailty is a term that is applied to elderly people who are at increased risk of 
mortality due to multiple problems with cognitive abilities, physical functioning, nutritional 
status, endocrine status, and quality of life.99  Some of the literature points to the loss in lean 
mass as the major predictor of functional decline and frailty, whereas others point to excess fat 
mass as the most important predictor.57, 301, 324, 326  According to Villareal et al., obesity was a 
major cause of physical dysfunction in community dwelling elderly.  However, the frailty of 
these obese elderly was also associated with a low amount of fat free mass, such as muscle, and 
poor muscle quality.323    
2.1.1 BODY FAT 
According to Villareal et al., obesity is defined as an unhealthy excess of body fat, which 
increases the risk of medical illness and premature mortality.322  While the prevalence of obesity 
has increased in all age groups in the last 25 years, the number of elderly obese has increased 
markedly because of both the increase in the number of older people and the increase in the 
number of older obese.81, 114, 159  In the age group 60-69 years of age, the prevalence of obesity 
increased from 14.7% in 1991 to 22.9% in 2000 and in the age group of greater than 70 years of 
age, the prevalence increased from 11.4% to 15.5%.195, 196   
 
Body mass index (BMI) is a measure used to classify medical risk by weight status in 
most populations.  This is usually due to the fact that the technology needed to assess body fat 
percentage is not readily available.  Also, it requires a knowledge base to perform and interpret.  
BMI is a measure of the relationship between height and weight and correlates with body fat 
percentage in the young and middle age adults.211, 214, 280, 332  .  In the elderly, however, BMI may 
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not be the best measure to use.  Older adults experience changes in body composition, and loss 
of height due to compression of the vertebral bodies and kyphosis, that alter the relationship 
between BMI and body fat percentage.299  This indicates that for any given BMI value, changes 
in body composition would tend to underestimate fatness, whereas the loss of height would tend 
to overestimate fatness.299   
 
Total fat mass increases with aging, with maximal fat mass usually being reached at 
approximately 60-70 years of age.27, 90   An important determinant of body fat mass at any age is 
the relationship between energy intake and expenditure.322  If energy expenditure decreases 
and/or energy intake increases, the result is an increase in body fat.  Many studies have suggested 
that energy intake does not change or may even decrease with age.92, 110  This would lead us to 
believe that a decrease in total energy expenditure is a major factor in the gradual increase in 
body fat with advancing age.   
 
Total energy expenditure is comprised of many components including:  resting metabolic 
rate (RMR), the thermic effect of food, and amount of physical activity.  Aging shows decreases 
in all of these components.  RMR is shown to decrease by 2-3% every decade after the age of 20 
years due partly to the decrease in fat free mass as we age.315  The thermic effect of food only 
contributes about 10% of total energy expenditure.  However, it has been shown to decrease by 
20% between young and older men.70, 275  For most individuals, physical activity also decreases 
with increasing age.  According to Elia et al., it has been estimated that the decrease in physical 
activity accounts for about one-half of the age-associated decrease in total energy expenditure 
that occurs with aging.70, 275   
 
Hormonal changes should also be considered when looking at the accumulation of fat 
mass with aging.  Hormonal alterations include a decrease in growth hormone, reduced 
responsiveness to thyroid hormone, decrease in serum testosterone, and resistance to leptin.  All 
of the factors contribute to the increase in fat, the reduction of fat-free mass and an energy 
imbalance.51, 183, 197, 274 
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Excess body fat and obesity are often associated with a myriad of health problems that 
lead to considerable morbidity, impaired quality of life, and premature death.322  However, many 
of the studies conducted on obesity-related complications were conducted on middle-aged adults, 
not elderly adults.  According to a study by Daviglus et al., excess weight gain in the young and 
middle-age years may translate to medical complications such as hypertension, diabetes, 
cardiovascular disease, and osteoarthritis, and increased Medicare expenditures that occur during 
old age.56   
2.1.1.1 REGIONAL BODY FAT 
 
Along with increased accumulation of total fat mass, aging is associated with a 
redistribution of body fat.322  Many studies have reported a positive association between age and 
visceral adipose tissue.154, 344  The viscera is defined as the region with borders at approximately 
T10-T11 and L5-S1 intervertebral spaces.341 Although the positive association of age and 
visceral fat is independent of gender, the age-related increase is greater in men than in women.154  
In women, the accumulation of visceral adipose tissue increases rapidly after menopause to a rate 
similar to that of men.154   
 
The health complications associated with increased visceral adipose tissue are vast.  A 
centrally located fat pattern is related to the development of diabetes, heart disease, and 
mortality.34, 78, 119, 279  Central adiposity has also been implicated in the development of blood 
lipid risk factors of cardiovascular disease44, 83, 123, 216 and hypertension.78, 321  All of these 
relationships with increased visceral adipose tissue endure even after accounting for the effects 
of increased total fat mass.166   
 
In particular, the risk factors for cardiovascular disease are more highly correlated with 
visceral fat than other fat distribution variables.38, 216  According to a study performed by 
Fujimoto using Japanese-American men, patients diagnosised with heart disease have relatively 
large intra abdominal fat stores.87 
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Metabolic syndrome, which is defined by a combination of risk factors including obesity, 
hypertension, hyperglycemia, and dyslipidemia, identifies individuals at increased risk of type 2 
diabetes and cardiovascular disease.102, 134  Metabolic syndrome has been associated with general 
obesity; however, it is now understood that distribution of body fat is an important determinant 
of metabolic abnormalities and is possibly more important than overall excess weight measured 
by BMI.328  Visceral fat accumulation is strongly associated with metabolic disturbances and 
insulin resistance.226, 241  In a 2003 study performed by Nguyen-Duy et al., visceral adipose tissue 
was found to be a significant predictor of lipid profile independent of abdominal subcutaneous 
adipose tissue202, which serves to strengthen the results of other studies in showing that visceral 
adiposity is a strong marker of metabolic risk.60, 227  In another study by Goodpastor et al.,  
visceral abdominal adipose tissue and intramuscular adipose tissue clearly differentiated those 
with metabolic syndrome, particularly among the non-obese.95  These results lead us to believe 
that metabolic syndrome can be present in older men and women with normal weight and 
relatively low total body fat due to the amount of intraabdominal and intramuscular adipose 
tissue.95  In this same study, the associations of subcutaneous adipose tissue and metabolic 
syndrome were much less robust or nonexistent.95  Greater subcutaneous adipose tissue in the 
thighs of obese men and women was actually associated with a lower prevalence of metabolic 
syndrome,95 which is consistent with other studies.316   
 
The association of excess visceral adipose tissue and increased risk of metabolic 
syndrome and cardiovascular disease has many possible explanations.   According to Bergman et 
al., visceral fat is thought to release fatty acids into the portal circulation, where they may cause 
insulin resistance in the liver and muscle.30  Ravussin et al. stated that the ability to store excess 
fat in adipose tissue is impaired leading to the ectopic storage of fat into nonadipose tissue such 
as muscle and liver.240 
2.1.1.2 EFFECT OF EXERCISE ON BODY FAT 
 
It has been well established that in adults, physical activity results in decreases in fat 
stores.  The inverse relationship between physical activity and body fatness is well 
documented.20, 62  These findings were further supported in a study by Hughes et al., in which 
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higher levels of physical activity were effective in decreasing body weight and body fat in an 
older (mean age 60.7years) population of men and women.125  Another study of middle aged 
women showed that the more aerobic physical activity they engage in and the greater the 
intensity and/or duration of that activity, the less body fat they have.313  A three year longitudinal 
study on elderly individuals revealed that leisure time physical activity did not prevent the 
decline in muscle mass and the increase in body fat; however, a higher level of physical activity 
was associated with higher muscle mass and less total and abdominal fat.235 No studies, however, 
have been found that look at the effect of elite competitive activity, including high levels of 
competitive activity into the 7th and 8th decade, on body fat accumulation and distribution. 
 
Regional body fat also seems to decrease with increases in physical activity, however, it 
is much less understood and researched.  One study reported an association between the lack of 
physical activity and an increase in abdominal adipose tissue.262  Several studies suggest that 
exercise may produce a preferential reduction in abdominal adipose tissue.61, 137, 139, 262, 263  In a 
study performed with older men and women, physical activity was inversely related with 
abdominal adipose tissue, even after controlling for age and gender.253 
2.1.2 MINERAL FREE LEAN MASS 
Aging is often associated with sarcopenia, a gradual reduction of skeletal muscle mass 
and a subsequent loss in strength.25, 27, 41, 170   According to Lexell et al., the average reduction in 
muscle area between 20 and 80 years of age was 40%, and the reduction began as early as 25 
years of age.172  Lexell also discovered that by the age of 50, only approximately 10% of muscle 
area was lost with an acceleration in loss there after.172  (Figure 1)  Two later studies confirmed 
the results of Lexell and his colleagues, reporting a decline in muscle area of 35-40% between 
the ages of 20 to 80 years.73, 80  Flynn et al., using total body potassium as an index of fat free 
mass, showed that men experience a more rapid loss in muscle mass between the ages of 41 and 
60, with women experiencing rapid loss after the age of 60 years.82   
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Figure 1  Relationship between age and muscle cross-sectional area.  Lexell et al. 1988 
 
Muscle atrophy has been shown to result from gradual and selective loss of muscle 
fibers.171  Lexell et al. showed a 23% decrease in the number of muscle fibers in the vastus 
lateralis muscle of older male cadavers as compared to young male cadavers.171  The decline is 
more apparent in type II, fast twitch muscle fibers.167, 230  Larsson documented this decline in 
type II muscle fibers at 60% in sedentary young men to below 30% after the age of 80.167, 230  In 
addition to the decline in muscle mass, many studies have found increases of fat and connective 
tissue within the older muscle.84, 212, 251  Overend et al., in particular, found increases in non-
muscle tissue of 59% in the quadriceps and 127% in the hamstrings.212   With this increase in 
age-related infiltration of fat and connective tissue, the reduction in muscle contractile tissue is 
greater than the actual reduction in muscle volume and muscle cross-sectional area.170    
According to Proctor et al., the infiltration of fat and connective tissue reduce the contractile 
tissue volume available for locomotive and metabolic functions and act as a “friction brake” to 
slow contractile velocity.230 
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2.1.2.1 EFFECT OF EXERCISE ON MINERAL FREE LEAN MASS 
 
Endurance exercise results in relatively small increases in the cross-sectional area of slow 
twitch muscle fibers.6  However resistance training shows increases in muscle mass by both 
increases in size and number of myofibrils in both fast-twitch and slow-twitch muscle fibers.144  
In older men and women, muscles adapt to resistance training with marked myofibril 
hypertrophy. 233, 287  One study reported similar gains in myofibril size in younger and older men 
following the same resistance training program.107  While resistance training results in marked 
increases in muscle mass in both genders, the response seems to be blunted in older women.130  
In one six month resistance training study, relative myofibril hypertrophy was 36% in men and 
only 7% in women.21  However no studies in the literature have looked at the effect of elite 
competitive participation in endurance exercise on the lean muscle mass in both elderly men and 
women. 
2.1.3 BONE MINERAL DENSITY 
Bone Mineral Density (BMD) is the measure frequently used to assess bone and accounts 
for approximately 70% of bone strength.273  Aging is associated with significant losses in bone 
mineral density in both men and women.255 Figure 2 is a compilation of numerous cross-
sectional and longitudinal studies using areal bone mineral density.  This figure illustrates the 
overall pattern of bone loss in both sexes.148  Menopause in women is associated with a rapid 
loss of trabecular bone.148  Trabecular bone is present in the vertebrae, pelvis, and ultra distal 
forearm. The loss of bone mineral density of trabecular bone is the primary cause of fragility in 
arrangement and architecture  of the spires of trabecular bone.45  Following menopause there is a 
less dramatic loss of cortical bone.45  Cortical bone is found in the long bones of the body and as 
a thin rim around the vertebrae and other sites of trabecular bone.  Men have a similar pattern of 
slow, age-related bone loss as women, however, they lack the equivalent of menopause and 
therefore do not exhibit this rapid phase of bone loss. 148 
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Figure 2  Patterns of age-related bone loss in women and in men.  Dashed lines represent trabecular 
bone and solid lines cortical bone. 
 
Peak bone mass occurs sometime between 18 and 30 years of age.45  Bone density 
naturally begins to decline after the third decade of life at a rate of 0.3% of bone per year in both 
men and women.3, 4, 29, 94, 285  Women accelerate this net bone loss about 10 fold for 
approximately 5 to 7 years beginning with the decrease in estrogen associated with 
menopause.182, 256, 257, 281  In women, 7 years after menopause, bone loss slows to approximately 
1% of bone per year.3, 4, 29, 94  Although women experience an accelerated rate of bone loss 
during and for years after menopause, constant bone loss affects both men and women over the 
age of 70 years.285  While accelerated bone loss is a large problem associated with aging and 
often the dominant effect in postmenopausal osteoporosis,  the main problem in older men and 
women is likely a decrease in synthesis of new bone in conjunction with either stable or 
accelerated bone loss.285 
 
 Extreme losses in bone mineral density can result in osteoporosis, which is defined as a 
disease of the skeleton characterized by low bone mineral density and micro-architectural 
deterioration of bone tissue that results in an increased susceptibility to fracture.5  Osteoporosis is 
a large public health problem that is responsible for more than 1.5 million fractures every year.17   
According to Bennett et al., thirty percent of women who suffer hip fractures related to 
osteoporosis die with in 1 year of injury, and another 25% remain permanently disabled.29  
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 Many factors affect bone mineral density including genetics, gender, race, nutritional 
factors, lifestyle factors, hormones, chronic diseases and medication, and body composition.11, 26, 
42, 59, 120, 121, 165, 169, 201, 210, 231, 236, 242, 244-246, 249, 277, 295, 303, 305, 307, 314, 325    Genetics may be the most 
important factor in determining an increased risk for osteoporosis.285  Gender and race are also 
crucial, as males have greater bone mass than females and that African-Americans and Hispanics 
have greater bone mass than Caucasians of the same age.28, 69, 97, 124, 147, 204, 284 However, many 
other factors play an important role in determining bone health.  Nutritional factors such as low 
dietary intake of calcium, phosphorous, and vitamin D are associated with age-related bone 
loss.276  Lifestyle factors such as lack of physical activity precipitate bone loss.  Physical activity 
has a protective effect on bone mineral density.115, 201, 231, 296, 304  Other important factors that 
contribute to decreased bone mass include late menarche and early menopause, caffeine 
ingestion, alcohol use and cigarette smoking.10, 16, 52, 55, 138, 150, 229, 278   
 
Obesity is also associated with higher bone mass.285    Although the protective effects of 
obesity on osteoporosis have been shown, it is not well understood exactly how obesity protects 
against osteoporosis.239, 311  Obesity related bone protective effects may be due to increased 
weight bearing, increased aromatization of androgen to estrogen in adipose tissue, lowered levels 
of sex hormone binding globulin, or a direct increased bone formation induced by high 
circulating levels of insulin.86, 149, 245, 247, 248, 267, 293    
 
According to Tabensky et al., individual peak bone mass and volumetric bone mineral 
density (bone size and amount of bone) affect age-related bone loss.309  This study conducted in 
women and their daughters concluded that reduced peak bone size and reduced peak volumetric 
bone mineral density during growth established the clinical relevance of bone loss during 
aging.309  Furthermore it suggested that in women with reduced peak bone size and reduced 
volumetric bone mineral density, age-related bone loss will be poorly tolerated and result in 
events such as non-traumatic vertebral fractures.309 
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2.1.3.1 REGIONAL BONE MINERAL DENSITY 
Bone mineral density is assessed in regional sections of the body.   Regional measures of 
bone mineral density are often taken at the lumber spine, femoral neck, and the wrist.  Bone 
Mineral Density is of particular interest in the lumbar spine and femoral neck because these two 
regions are sites of major bone fractures.111, 145, 283  Colles’ fractures, a common term to refer to 
distal radius fractures, are also common and incidence increases in women after menopause, 
however there is no increase in Colles’ fractures for men with age until after the age of 80 
years.191  Patterns of bone loss differ for the lumbar spine, femoral neck, and femoral shaft in 
women.232   For example many studies have reported that bone loss at the femoral neck begins in 
the mid-20s and continues throughout life.18, 175, 192  However, in a study by Slemenda et al., the 
bone loss in the femoral neck did not correspond with bone loss at the spine or forearm in 
women during the same years.292  In men, little research has been done on the rate of regional 
bone loss.  One relatively small cross-sectional study found that in men there were no age-related 
decreases in bone mineral density at the lumbar spine, trochanter, ultra-distal forearm, radius, 
ulna, or head, but the decreases in bone mineral density were substantial with age at the pelvis 
and proximal femur.76  
2.1.3.2 EFFECTS OF EXERCISE ON BONE MINERAL DENSITY 
Exercise can be categorized based upon aerobic level and amount of force borne by the 
body; for example aerobic, weight bearing exercise; aerobic non-weight bearing exercise; and 
resistance training (ie: high muscle load activity).  Most bone mineral density studies focus on 
weight bearing exercise, such as running, where the participant’s skeleton supports the entire 
mass of the body during the exercise, and non weight bearing exercise, such as swimming, where 
the body mass is supported by the water.   
 
Because accumulation of bone mass occurs primarily in childhood and adolescence, 
many studies have investigated the effect of weight bearing exercise in children.35, 127, 176 Regular 
participation in weight bearing activity has been associated with higher bone mineral density in 
children and higher peak bone mass in the young adult.98, 294, 331  It has also been shown that 
physical activity during childhood is associated with higher bone mineral density in adolescence 
and young adulthood.50, 331  However, few studies have gone so far as to say that weight bearing 
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physical activity during adolescence maximizes the peak bone density achieved in adulthood.100, 
206, 331  Welten et al. also reported that weight bearing physical activity in childhood is more 
influential than calcium intake in reaching the highest peak adult bone mass.331  Additionally, 
Hui et al. stated that peak bone mass accounts for at least half of the variation in bone mass in the 
elderly.128 
 
Exercise modulates bone mineral density in adults. A cross-sectional study of female 
athletes aged 18-69 years, demonstrated that lumbar spine and femoral neck bone mineral 
density, but not total body bone mineral density, declined with age but at a lesser rate than that of 
the general population.270  Another study found that 40-65 year old ex-athletes had higher lumbar 
and femoral bone mineral density than their age matched controls.72  Although data on males in 
this area are limited, a few cross-sectional studies have shown the positive effect of exercise on 
bone mineral density in adult males.178, 209, 269, 340  Longitudinal data would provide the clearest 
answer to the effect of exercise on bone mineral density, however these types of studies are 
lacking.   
 
Cross-sectional studies of athletes from different sports compared with non-athlete 
controls show that weight bearing sports are generally more osteogenic than non weight bearing 
activities.68, 116 In a study comparing athletes in three sports, Judo, Karate (high impact weight 
bearing sports) and water polo (non weight bearing sport) to non-athlete controls, Andreoli et al. 
found that although the athletes as a whole had better bone mineral density than the controls.  
The athletes in weight bearing sports, Judo and Karate, had significantly higher bone mineral 
density than that of the athletes who played water polo.12  Also, in studies of athletes, researchers 
have found that skeletal adaptations in regional bone density seem to be site specific due to the 
loading requirements of the specific sport or activity.39, 141  For example, a study with female 
volleyball and basketball players showed higher bone mineral density of the calcaneus and the 
lumbar spine in the athletes compared with non-athletes controls.261  This is not only true when 
comparing bone density across populations, but is true of the loading differences within the 
individual.  Among athletes and sedentary individuals alike, studies have found that the 
dominant arm of an individual has higher bone mineral density than that of the non-dominant 
arm.222, 252 
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2.1.4 DXA 
Dual energy x-ray absorptiometry (DXA) has been shown to be an effective measure of 
body composition and is considered a valid and reliable reference measure.71, 174, 335  DXA shows 
a three-dimensional model of body composition and takes into account bone free lean mass, fat 
mass, and bone mass.2, 329  DXA provides accurate information regarding bone mineral content, 
areal bone density, and has been suggested as a criterion method for measuring percent fat.152, 185 
DXA has been shown to give accurate measures of whole body as well as regional bone mineral 
density, percent fat, and lean muscle mass with a small precision error which is comparable or 
smaller than those achieved with other types of noninvasive methods.118, 185 
 
2.2 MUSCLE STRENGTH 
Muscle strength is defined as the ability of a muscle to exert force.336  Many factors 
determine muscle strength including type of muscle fiber, size of the muscle, and length and 
speed of the muscle at contraction.88  Fast twitch muscle fibers show a faster time to peak tension 
than slow twitch fibers.  Recent research has shown considerable evidence that fast twitch fibers 
produce a greater magnitude of contraction force than slow twitch, however there is significant 
controversy over this suggestion.88, 228  The basic premise regarding muscle size is that larger 
muscles are stronger than smaller muscles.88  Muscle mass, the cross-sectional area of the 
muscle, is often a better determinant of muscle size than the more clinically used muscle 
circumference.  Circumference of the muscle often overestimates muscle size because fat, fluid, 
bone, skin, vasculature and other tissues are included.  Therefore, muscle mass is a more 
accurate measurement of how much muscle is available to produce strength.88  As the cross-
sectional area of the muscle increases, so does the amount of contractile proteins, actin and 
myosin, which ultimately results in greater force production.88  Another factor affecting muscle 
strength is muscle length.  Maximum force is generated near its resting length.  If the muscle 
length changes, either shorter or longer, the force is reduced.188 
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Gender also has an affect on muscle strength.88  Men have significantly higher absolute 
and relative strength than women.46, 143, 173, 177, 221, 291  Until recently, the consensus has been that 
men and women have similar muscle quality (peak torque per unit of muscle mass)194, 243; 
however, a 1999 study reported that men have higher muscle quality than women, for both arm 
and leg muscles.177   
 
 The human aging process also has a profound effect on muscle strength.  Many cross-
sectional studies of limb muscles in healthy young, middle aged, and older men and women, 
utilizing both dynamic and isometric testing methods, show an age-related decline in muscle 
strength.  65, 225, 317 Some data indicate that strength peaks in the third decade and remains 
relatively unchanged or slightly decreases to the fifth decade.132  The age-related decreases in 
strength are on average 20-40% with even greater losses, approximately 50% or more, reported 
for individuals in their 9th decade.168, 199, 200, 342, 343  The relative losses in muscle strength appear 
to be similar for both men and women.64  Few longitudinal studies have been performed; 
however, they have reported larger losses of strength than the cross-sectional studies.22, 47  
Longitudinal studies have reported annual decline rates ranging from 1.4 to 5.4% in both men 
and women13-15, 22, 237, 338    No studies have been conducted that compare the strength of elite 
senior athletes who have been competitively active for the majority of their lives with healthy 
community dwelling seniors.    
2.2.1 RELATIONSHIP OF MUSCLE MASS AND MUSCLE STRENGTH 
Muscle mass has a high correlation with muscle strength177  leading some to conclude 
that the loss in muscle strength is due entirely to the loss in muscle mass.318  There is conflicting 
literature on the association of the changes of muscle mass and muscle strength.  In one 
longitudinal study, muscle mass changes only accounted for 5% of the variance in knee 
strength.126  A significant association between the change in muscle strength and mass with 
exercise or detraining is rarely observed.104, 306  Disproportionate gains in strength and muscle 
mass, with large gains in strength but small increases in lean muscle mass, have been shown in 
intervention studies.85  This may indicate that other neuromuscular changes may mediate muscle 
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strength decreases.126  However, some studies suggest that muscle mass explains most of the 
variance in muscle strength.63, 193, 243 
 
2.2.2 RELATIONSHIP OF BONE MINERAL DENSITY AND MUSCLE STRENGTH 
The data on the relationship of bone mineral density and muscle strength is conflicting.  
Some studies have documented positive correlations between muscle strength and bone mineral 
density.32, 33, 155, 203, 223, 320, 327 Studies by Hyakutake et al. and Madsen et al. demonstrated a 
relationship between muscle strength and the bones in which they act upon in non-athletes.133, 180  
The association between muscle strength and bone mineral density seems to be more prominent 
among sedentary individuals and those with low to moderate levels of physical training, while in 
highly trained individuals there is little or no relationship between muscle strength and bone 
mineral density.  7, 8, 205, 207, 208, 272, 308  Also, significant correlation between isometric strength of 
the quadriceps muscle and bone mineral density in both young adult women and pre- and post-
menopausal women on hormone replacement therapy has been found, whereas no correlation 
between muscle strength and bone mineral density was found in men.250  Several other studies 
reported muscle strength to be a predictor of bone mineral density independent of body weight in 
women and men. 93, 109, 180, 204, 297, 298  A recent study demonstrated a positive relationship 
between quadriceps muscle strength and bone mineral density of all measured sites except the 
forearm.67  No studies have reported data on lifelong master athletes. 
2.2.3 EFFECT OF EXERCISE ON MUSCLE STRENGTH 
Different types of exercise affect muscle strength in different ways. Resistance trained 
muscles exert considerably more force because of both increased muscle size and increased 
muscle fiber recruitment.144 This increase in muscle size is due to the increase in size and 
number of myofibrils in both the fast and slow twitch muscle fibers. Many resistance training 
intervention studies have shown the changes in strength are similar in both young and old 
individuals when presented with the same progressive resistance training program106, 140, 330 One 
study found that older subjects significantly increased the amount of maximum force generated 
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by 174% +/- 31% following high intensity isotonic training.77  Many strength training studies in 
older adults typically show gains in strength beyond what would be anticipated by the increases 
in muscle mass.131, 135, 310, 312  These disproportionate increases may be explained by an increase 
in motor unit activation.103, 105, 198   
 
Endurance training has also been shown to increase muscular strength.  Significant 
improvements in lower limb strength after participation in aerobic exercise training programs 
have been reported in many studies.31, 49, 112  This was supported by a study on older adults, 
where relative improvements of 1-RM knee extensors and flexors strength were 12% and 19% 
respectively following a 12 week aerobic exercise program.142   
 
2.2.4 ISOMETRIC STRENGTH TEST 
Strength is defined as the ability of a muscle to develop tension and exert force on a bony 
lever.156  Strength is often assessed using an isometric contraction.   An isometric contraction 
involves a maximal voluntary contraction performed at a specified joint angle against an 
unyielding resistance337  The amount of tension developed in a muscle is determined by the 
number of bridges formed between the actin and myosin filaments as they slide past each other 
during a contraction.  Theoretically, according to Murray et al., in an isometric contraction there 
is sufficient time for the maximum number of cross-bridges to be formed allowing for the 
maximum tension to develop.200  Position of the knee during the isometric contraction is very 
important.    A study by Murray et al. showed that position had little effect on the average 
strength for knee flexor muscles, but for extensor muscles the average isometric strength values 
at the 30 degree position were significantly lower than the values at 45 and 60 degrees.   
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2.3 NATIONAL SENIOR GAMES (IE: THE SENIOR OLYMPICS) 
The National Senior Games began in 1985 with the first games taking place in St. Louis, 
Missouri.  In St. Louis, 2,500 senior athletes from 33 states participated in the first “Senior 
Olympics”.  In 1987, an agreement was reached with United States Olympic Committee based 
on their objection to the use of the term Olympic in the organization’s corporate name and the 
name was changed to the U.S. National Senior Sports Organization.  The designation of “Senior 
Olympics” is still allowed to be used in the original states.  The National Senior Games 
Association is a not-for-profit organization dedicated to motivating active adults to lead a healthy 
lifestyle through the senior games movement.  The Summer Games event has grown to one of 
the largest multi-sport events in the world. The 2005 Summer Games were held in Pittsburgh, 
Pennsylvania where 10,500 athletes participated.   
 
Athletes qualifying for the National Senior games must be 50 years of age on or before 
December 31st of the year before the Summer Games.  All athletes competing in individual 
competitions are divided into five year age categories (i.e. 50-54, 54-59, 60-64 etc).  All athletes 
must qualify at “Qualifying Games” held in each state.  Each event has different numbers of 
qualifiers they will accept, however, each athlete must meet the minimum qualifying 
performance set by the National Senior Games Association.     
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3.0  METHODOLOGY 
3.1 SUBJECTS 
One hundred male and female master athletes > 65 years of age were recruited from the 
Summer 2005 National Senior Games (i.e. the Senior Olympics) held at the University of 
Pittsburgh from June 3-20, 2005.  The National Senior Games occur biannually and encompass 
athletes from all states except Alaska.  Over 250,000 individuals participate in one of 19 sports at 
the community level.  The top five finishers in each age category in each sport move on to 
compete at the state level, resulting in 12,000 medalists that qualify to compete at the National 
Games.  Subjects were recruited from the following sports 1) running [events with distances > 
400 meters, n=43], 2) cycling [all events, n=16], and 3) swimming [all events, n=41]. During the 
following summer, 2006, a control group of 86 sedentary men and women > 65 years of age 
were recruited from the University of Pittsburgh Claude D. Pepper Older Americans 
Independence Center. All subjects completed the same protocol.  All participation was voluntary.  
We excluded master athletes and controls who were on medications that can prevent bone loss 
(e.g., bisphosphonates, hormone replacement therapy, SERMs, and parathyroid hormone) or 
cause bone loss (glucocorticoids, certain anticonvulsants).   
 
All procedures were approved by the University of Pittsburgh Institutional Review Board 
committee prior to data collection.  Each subject was required to be present for one study visit 
lasting approximately 2 ½ to 3 hours.  Subjects were prescreened over the telephone and then 
consented for the study at the General Clinical Research Center (GCRC) in UPMC Montefiore 
University Hospital prior to any study procedures. 
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3.2 SUBJECTS 
Subjects for this investigation included 186 individuals aged 65 and older.  Subject 
descriptive data are presented in Tables 1 and 2. 
Table 1 Control Demographics 
 Age (yr) Height (in) Weight (lbs) Body Fat (%) 
Males (n=52) 74.15 ± 5.05 68.06 ± 2.33 180.29 ± 22.04 25.07 ± 5.67 
Females (n=34) 77.09 ± 5.47 62.97 ± 2.68 167.03 ± 30.23 38.77 ± 5.93 
Total (n=86) 75.31 ± 5.38 66.05 ± 3.51 175.05 ± 26.24 30.20 ± 8.80 
 
Table 2 Athlete Demographics 
 Age (yr) Height (in) Weight (lbs) Body Fat (%) 
Males (n=61) 73.10 ± 6.86 68.30 ± 2.43 170.52 ± 25.63 21.65 ± 5.74 
Females (n=39) 72.03 ± 6.31 63.28 ± 2.50 142.10 ± 27.66 30.68 ± 7.55 
Total (n=100) 72.68 ± 6.64 66.34 ± 3.47 159.44 ± 29.76 25.15 ± 7.83 
 
 
 
3.2.1 INCLUSION/EXCLUSION CRITERIA 
3.2.1.1 SENIOR ATHLETE GROUP 
 
We excluded any master athletes who had a history of the following:   
? Medications that can prevent bone loss (e.g., oral or intravenous bisphosphonates, calcitonin, 
SERMs, and parathyroid hormone) or cause bone loss (glucocorticoids for greater than 3 
months over the last year, certain anticonvulsants, anabolic steroids); 
? Diseases known to affect bone mineral metabolism (hyperthyroidism, hyperparathyroidism, 
end stage renal or liver disease); 
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? A history of cancer within the past 5 years, though subjects with a more recent history of 
relatively benign skin cancers such as basal cell or squamous cell carcinoma are not 
excluded; 
? Bilateral hip replacement or lumbar spine surgery; 
? Master athletes who participate in the triathlon or two separate impact categories. 
 
Subjects were included in the study if they met the following criteria: 
? Male and female master athletes ages > 65 years who are entered in the following events at 
the Summer 2005 Senior Olympics and who participate in only one of these impact 
categories: 1) high-impact sports (running [including events > 400 meters, n=40]); 2) 
medium-impact sports (cycling [including all events, n=40]); and 3) low-impact sports 
(swimming [including all events, n=40]).  
? We attempted to recruit subjects so that the three groups will have similar age and gender 
composition to facilitate a matching of subjects across groups. 
3.2.1.2 CONTROL GROUP 
We excluded any control subjects who had a history of the following:   
? Medications that can prevent bone loss (e.g., oral or intravenous bisphosphonates, calcitonin, 
SERMs, and parathyroid hormone) or cause bone loss (glucocorticoids for greater than 3 
months over the last year, certain anticonvulsants, anabolic steroids); 
? Diseases known to affect bone mineral metabolism (hyperthyroidism, hyperparathyroidism, 
end stage renal or liver disease); 
? A history of cancer within the past 5 years, though subjects with a more recent history of 
relatively benign skin cancers such as basal cell or squamous cell carcinoma are not 
excluded; 
? Bilateral hip replacement or lumbar spine surgery; 
 
Subjects were included in the study if they met the following criteria: 
? Male and female healthy community dwelling seniors ages > 65 years; 
? Do not participate as a competitive master athletes. 
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3.3 METHODS 
This was a cross-sectional study to determine various components of body composition 
and muscle strength between life-long athletes and sedentary controls over the age of 65.  All 
data were collected at the General Clinical Research Center (GCRC) at Montefiore University 
Hospital. 
3.3.1 PRE SCREENING 
All subjects were screened by telephone prior to acceptance into the study.  A waiver to 
document the informed consent for the telephone screening questionnaire was requested from the 
University of Pittsburgh IRB.  This request was made due to the fact that screening questions 
present no more than minimal risk of harm to the subjects and involve no procedure for which 
written consent is normally required outside of the research context. The telephone screening 
included questions on age, medications, current health problems, and impact-level of sporting 
events.  Subjects were then informed if they qualified for the study and were scheduled 
accordingly.   
3.3.2 BODY COMPOSITION 
Body composition was measured by dual-energy x-ray absorptiometry (DXA) using a 
Hologic QDR-4500A (Bedford, MA).  DXA provides state-of-the-art accuracy and precision.  A 
licensed DXA technician performed all of the data collection and analysis procedures.  The DXA 
scans provided measures of bone mineral density, bone mass, mineral free lean mass, and fat 
mass.  Regional measures (trunk, legs and arms) of body composition were provided.  Regional 
measures of body fat (in grams) and lean tissue (in grams) measures were converted to percent of 
total body by dividing the measure by the total grams of the body, as measured by DXA.  Each 
scan lasted approximately 1-5 minutes and was a noninvasive, low-radiation procedure.  Quality 
control was assured with a daily measurement of a spine phantom of defined hydroxyapetite 
composition.   
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3.3.3 LOWER EXTREMITY MUSCLE STRENGTH ASSESSMENT 
 
Figure 3 Custom designed aluminum chair 
 
Muscular strength was measured with a tension/compression load cell (Lebow Model 
3132, Columbus, OH) We measured isometric strength of the quadriceps and hamstrings on the 
subject’s left side.  The left side was chosen because that is the side on which hip bone density 
was measured.  The load cell was attached to an adjustable bar, which was attached to a metal 
bar secured to a custom designed aluminum chair. (Figure 3)  This allowed for adjustments to be 
made for leg length differences of the subjects.  The load cell was calibrated daily using 10lb and 
35lb weights.  All calibration equations have been saved and will be used to analyze all data. 
 
Subjects were placed in a comfortable seated position on the chair, and secured using a 
seatbelt positioned at the hips to minimize extraneous body movements.  The hip was positioned 
in 90º of flexion.  The knee was positioned in 45º of flexion.  The adjustable bar to which the 
load cell was attached was positioned just proximal to the malleoli.  The distance from the knee 
to the adjustable bar was recorded in order to calculate torque.  The subjects were asked to 
position their arms either crossed at the chest level or resting on their lap in order to avoid 
bracing or pulling on the chair. The correct positioning of a subject in the chair is illustrated in 
Figure 4.     
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Figure 4 Subject performing hamstring strength assessment. 
 
The gravity effect torque was calculated based on the subject’s leg weight at this angle.  
Subjects performed 3 repetitions of maximal isometric knee extension lasting 5 seconds each.  
Thirty seconds of rest were provided between contractions.  Similarly, subjects performed three 
repetitions, each lasting 5 seconds, of maximal isometric knee flexion.  Thirty seconds of rest 
were provided between contractions.  Torque was calculated as the product of the force in the 
load cell times the distance from the knee to the adjustable bar.  Peak torque and peak torque to 
body weight ratio was recorded.  Isometric peak torque has an intraclass correlation coefficient 
of greater than 0.89.40 
 
Subjects were instructed to continue breathing during the tests and to not hold their breath 
in order to prevent the subjects from doing the Valsalva maneuver during the tests.  The subjects 
were also instructed that they could stop the test at any time.  During the test, subjects were 
instructed to begin and were encouraged to “push” for the extension trials and to “pull” for the 
flexion trials.  The test adminstrator repeated the word push/pull each second for a total of five 
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seconds.  The subject was then instructed to relax at the conclusion of each trial.  This entire 
procedure was repeated for a total of three trials of extension and three trials of flexion.  The 
instructions and encouragement were consistant for all of the subjects, both athletes and controls.  
The order of exercises was counterbalanced for all subjects to ensure acuracy.   
3.3.4 MISCELLANEOUS 
This study was a part of a larger study named  “The Effect of High Impact Exercise on 
Skeletal Integrity in Master Athletes”,  with Susan Greenspan, MD as the Principal Investigator.  
This study examined bone mineral density, lower extremity muscle strength, biochemical 
markers of bone turnover, measures of bone and mineral metabolism, and gonadal status in 104 
master athletes who participated in the 2005 Summer Olympic Games in Pittsburgh and 
sedentary controls from the Greater Pittsburgh Area.  The specific aims of this study were as 
follows: 
To determine the differences among  high-impact sports (running) versus medium-impact 
sports (cycling) or low impact sports (swimming) in: 
1) bone mass in the spine, hip, forearm, and heel,  
2) lower extremity strength,  
3) biochemical markers of bone turnover,  
4) indices of bone and mineral metabolism or gonadal status.  
3.4 STATISTICS 
This is a cross-sectional study to determine various components of body composition and muscle 
strength between lifelong athletes and sedentary controls over the age of 65.  All statistical 
analyses were performed using SPSS 13.0 Statistical Software (Lead Technologies Inc., 
Chicago, IL).  Initial analysis began with calculating descriptive statistics, including measures of 
central tendency (means, medians, other percentiles) and dispersion (standard deviations, ranges) 
for controls and senior athletes.  Significance was determined at a p-value of 0.05. 
 45 
  To test hypothesis 1, three separate,  two factor ANOVA (Gender X Group) on arm, leg 
and abdominal adiposity values were performed to determine differences between groups.    
 
To test hypothesis 2, two separate, two factor ANOVA (Gender X Group) on arm and leg 
mineral free lean mass were performed to determine differences between groups. 
 
To test hypothesis 3, two correlational analysis for each group were performed on 
quadriceps strength and thigh mineral free lean mass, and hamstring strength and thigh mineral 
free lean mass. 
 
To test hypothesis 4, three correlational analyses for each group were performed on 
regional mineral free lean mass and bone mineral density (arm mineral free lean mass and wrist 
bone mineral density;  leg mineral free lean mass and hip bone mineral density; trunk mineral 
free lean mass and lumbar spine bone mineral density) 
 
To test hypothesis 5, six correlational analysis for each group were performed on regional 
fat mass and bone mineral density (arm fat mass and wrist bone mineral density;  leg fat mass 
and hip bone mineral density; trunk fat mass and lumbar spine bone mineral density; arm fat 
mass and total bone mineral density;  leg fat mass and total bone mineral density; trunk fat mass 
and total bone mineral density) 
3.5 CALCULATIONS 
Because the participants in the study vary greatly in height and weight, several 
calculations needed to be made in order to compare individuals.  Strength data, reported in Nm, 
were normalized to body weight and height by dividing the calculated torque by the person’s 
body weight and height. Regional measures of body fat (in grams) and lean tissue (in grams) 
measures were converted to percent of total body by dividing the measure by the total grams of 
the body, as measured by DXA.  This allowed for comparisons between subjects on all measures. 
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4.0  RESULTS 
Dual-energy x-ray absorptiometry was utilized to examine the body composition of male 
and female elite senior athletes and healthy community dwelling controls.  Specifically, 
measures of fat mass and mineral free lean mass were compared.  Measures of bone density were 
also obtained.  Similar group and gender comparisons on the bone density data were performed 
by other members of our research team and are presented elsewhere.302, 319  The relationships 
between the measures of mineral free lean mass and thigh muscle strength, body fat and thigh 
muscle strength, mineral free lean mass and bone mineral density, and body fat and bone mineral 
density were also examined. 
4.1 REGIONAL ADIPOSITY 
Two-factor analyses of variance (group X gender) were performed to test the differences 
in regional adiposity between group and gender.  There were no significant gender by group 
interactions for percent body fat in the trunk and the leg.  The interaction was significant for 
percent body fat in the arm, but it was ordinal in nature.  In other words, both female and male 
athletes had lower percentage of body fat than their control counterparts. (ANOVA tables located 
in Appendix A.1) Therefore, to directly address the question of whether significant differences 
were present between athletes and controls within each gender, six one factor analyses of 
variance (group) were performed.  For both females and males, controls had a significantly 
higher body fat percentage in every body region examined than did athletes.  The findings are 
presented in the following table. 
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Table 3  Comparison of Regional Body Fat for each gender between Athletes and Controls 
 Variables Athletes  Controls P-value 
% Body fat Left Arm 1.81 ± .57 2.21 ± .48 p = .003* 
% Body fat Trunk 14.08 ± 4.71 18.67 ± 4.07 p < .001* 
Females 
% Body fat Left Leg 5.82 ± 1.38 7.02 ± 1.50 p = .001* 
% Body fat Left Arm 1.17 ± .33 1.31 ± .32 p = .033* 
% Body fat Trunk 11.25 ± 4.07 13.56 ± 3.65 p = .003* 
Males 
% Body fat Left Leg 3.17 ± .94 3.79 ± 1.12 p = .002* 
* denotes significance at p < .05 
4.2   REGIONAL MINERAL FREE LEAN MASS 
Two separate 2 factor (Gender X Group) analyses of variance (ANOVA) were used to 
compare regional measures of mineral free lean mass (MFL) between subjects. In the arm and 
leg, mineral free lean mass is predominately comprised of muscle tissue.  Mineral free lean mass 
for the abdomen is comprised of both muscle tissue and internal organs.  Similar comparisons 
were not made of abdominal mineral free lean mass because of the confounding factor of organ 
tissue in the measurement. 
 
There were no significant gender by group interactions for percent mineral free lean mass 
of the arm or leg.(ANOVA tables located in Appendix A.2)  Therefore, to directly address the 
question of whether significant differences were present between athletes and controls within 
each gender, four one factor analyses of variance were performed. In both males and females, 
athletes had a significantly higher percentage of mineral free lean tissue of the arm and leg than 
controls.  The findings are presented in the following table. 
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Table 4  Comparison of Mineral Free Lean Mass for each gender between Athletes and Controls  
 Variables Athletes  Controls P-value 
% MFL Left Arm 3.20 ± .51 2.83 ± .47 p = .003* Females 
% MFL Left Leg 10.72 ± 1.46 9.59 ± .96 p = .001* 
% MFL Left Arm 4.33 ± .45 4.05 ± .50 p = .002* Males 
% MFL Left Leg 12.38 ± 1.25 11.39 ± 1.16 p < .001* 
* denotes significance at p < .05 
4.3 RELATIONSHIP BETWEEN MINERAL FREE LEAN MASS OF THE LEFT LEG AND 
STRENGTH 
Three separate one-tailed correlational analyses were performed to determine the 
relationship between % mineral free lean tissue of the left leg and measures of thigh muscle 
strength in athletes, controls and a combined sample of athletes and controls.  The findings are 
presented in the following three tables.  All of the correlations were statistically significant.  The 
relationship between extension strength and mineral free lean mass was stronger in the control 
group, while the relationship between flexion strength and mineral free lean mass was stronger in 
the athletes.  Normalizations of the strength data to body weight and height resulted in stronger 
relationships than did the raw torque values.  
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Table 5 Correlational analysis on MFL and strength measures for a combined sample of athletes and 
controls 
 % MFL in Left Leg 
 r value p-value 
Flexion Peak Torque Nm .411 p < .001* 
Flexion Peak Torque BW*Hgt .489 p < .001* 
Extension Peak Torque Nm .517 p < .001* 
Extension Peak Torque BW*Hgt .603 p < .001* 
 
 
Table 6  Correlational analysis on MFL and strength measures for a sample of athletes only 
 % MFL in Left Leg 
 r value p-value 
Flexion Peak Torque Nm .348 p < .001* 
Flexion Peak Torque BW*Hgt .472 p < .001* 
Extension Peak Torque Nm .365 p < .001* 
Extension Peak Torque BW*Hgt .509 p < .001* 
 
 
Table 7  Correlational analysis on MFL and strength measures in a sample of controls only 
 % MFL in Left Leg 
 r value p-value 
Flexion Peak Torque Nm .258 p = .013* 
Flexion Peak Torque BW*Hgt .264 p = .011* 
Extension Peak Torque Nm .586 p < .001* 
Extension Peak Torque BW*Hgt .615 p < .001* 
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4.4 RELATIONSHIP BETWEEN REGIONAL MINERAL FREE LEAN MASS AND 
REGIONAL BONE MINERAL DENSITY 
Two separate one-tailed correlational analyses were performed to determine the 
relationship between regional % mineral free lean tissue and its corresponding regional bone 
mineral density in athletes, controls, and a combined sample of athletes and controls.   
 
In a combined sample of athletes and controls a significant correlation (r = .248, p = .001) 
was found between bone mineral density of the total hip and the % mineral free lean tissue of the 
left leg.  A significant correlation (r = .640, p < .001) was also found between bone mineral 
density of the total radius and the % mineral free lean tissue of the left arm.  (Results 
summarized in figures 5 & 6) 
 
When this relationship is examined in athletes alone, a significant correlation (r = .196,   
p = .030) was found between bone mineral density of the total hip and the % mineral free lean 
tissue of the left leg.  A significant correlation (r = .548, p < .001) was also found between bone 
mineral density of the total radius and the % mineral free lean tissue of the left arm.  (Results 
summarized in figures 5 & 6) 
 
When the data of the controls alone were studied, a significant correlation (r = .375,        
p = .001) was found between bone mineral density of the total hip and the % mineral free lean 
tissue of the left leg.  A significant correlation (r = .745, p < .001) was also found between bone 
mineral density of the total radius and the % mineral free lean tissue of the left arm.  (Results 
summarized in figures 5 & 6) 
 
The relationships between bone mineral density of the hip and percent mineral free lean 
tissue, and between bone mineral density of the wrist and percent mineral free lean mass of the 
arm were strongest in the control group.  
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Figure 5 Scatterplot for % MFL of the left arm and BMD of the total radius 
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Figure 6  Scatterplot for %MFL of the left leg and BMD of the total hip 
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4.5 RELATIONSHIP BETWEEN REGIONAL FAT MASS AND REGIONAL BONE 
MINERAL DENSITY 
Six separate one-tailed correlational analyses were performed to determine the 
relationship between regional % body fat and its corresponding regional bone mineral density in 
athletes, controls and a combined sample of athletes and controls.  Specifically, radius BMD and 
arm percent body fat, spine BMD and trunk percent body fat, hip BMD and leg percent body fat 
were compared. 
 
In a combined sample of athletes and controls, a significant negative correlation              
(r = -.508, p < .001) was found between bone mineral density of the total radius and the % body 
fat of the left arm.  No correlation (r = .000, p = .498) was found between bone mineral density 
of the total spine and the % body fat of the trunk.  A significant negative correlation (r = -.386,   
p < .001) was found between bone mineral density of the total hip and the % body fat of the left 
leg.  (Results summarized in figures 7, 8 & 9) 
 
When only the athletes are studied, a significant negative correlation (r = -.407, p < .001) 
was found between bone mineral density of the total radius and the % body fat of the left arm.  
No significant correlation (r = .028, p = .397) was found between bone mineral density of the 
total spine and the % body fat of the trunk.  A significant negative correlation (r = -.338,             
p < .001) was found between bone mineral density of the total hip and the % body fat of the left 
leg.  (Results summarized in figures 7, 8 & 9) 
 
When this relationship is examined in control subjects alone, a significant negative 
correlation (r = -.615, p < .001) was found between bone mineral density of the total radius and 
the % body fat of the left arm.  No significant correlation (r = .164, p = .070) was found between 
bone mineral density of the total spine and the % body fat of the trunk.  A significant negative 
correlation (r = -.466, p < .001) was found between bone mineral density of the total hip and the 
% body fat of the left leg.  (Results summarized in figures 7, 8 & 9) 
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The relationships between bone mineral density of the total radius and the percent body 
fat of the left arm, and the bone mineral density of the total hip and percent body fat of the left 
leg were strongest in the control group.  However, no significant correlations were found 
between bone mineral density of the total spine and percent body fat of the trunk in any group.  
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Figure 7 Scatterplot for % body fat of the left arm and BMD of the total radius 
 
 55 
25.0020.0015.0010.005.00
% Body Fat in Trunk (using total grams
from DXA)
1.75
1.50
1.25
1.00
0.75
0.50
S
pi
ne
B
M
D
Fit line for Control
Fit line for Athlete
Fit line for Total
Control
Athlete
Athlete or Control
R Sq Linear = 9.598E-8
R Sq Linear = 7.649E-4
R Sq Linear = 0.027
 
Figure 8  Scatterplot for % body fat of the trunk and BMD of the total spine 
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Figure 9  Scatterplot for % body fat of the left leg and BMD of the total hip 
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5.0  DISCUSSION 
The purpose of this cross-sectional study was to determine the difference between various 
components of body composition in elite competitive older athletes and community-dwelling 
ambulatory controls and to examine the interrelationships between the components of body 
composition, and between these components and strength; specifically, to examine the 
relationship between the muscle mass and strength, regional body fat distribution and strength, 
and regional body fat distribution and muscle mass, bone mineral density and bone mass in 
community-dwelling ambulatory controls and elite competitive older athletes.  Although many 
studies have examined the relationship between body composition parameters and age in older 
subjects, none have compared clinical normal community dwelling elderly aged 65 and older and 
what is often referred to as the ideal model of aging, the elite competitive athletes aged 65 and 
older.27, 90, 146  Our predominant findings were that, as expected, all regional measures of body fat 
were significantly higher in control subjects than in athletes.  This study also showed that all 
regional measures of lean muscle mass were significantly greater in athletes than in control 
subjects.   
5.1 BODY FAT 
Our study showed that all regional measures of body fat were significantly less in athletes 
than in control subjects.  This indirectly corroborates previous studies that reported decreases in 
total and abdominal fat with physical activity.20, 62, 124, 253  Protective effects of physical activity 
on the prevention of weight gain in middle-aged subjects has been widely reported and are often 
attributed to the increase in energy expenditure with physical activity.101, 163, 260, 334  Previous 
studies have shown an increase in total and abdominal fat with aging.27, 90, 154, 344  Most studies 
attribute the gain in total and abdominal fat with aging to a decrease in resting metabolic rate, 
thermic effect on food and decrease in physical activity.70, 275, 315 
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 Our study also showed that women in both the athlete and control groups had a 
significantly higher percentage of body fat in the arm, trunk and leg than did males.  This is 
contrary to most data that show men have a higher percentage of abdominal fat than women, 
however it does support the data from the same studies that state that men have less overall body 
fat than women.238 
 
Studies that examined the body fat of college-aged competitive athletes showed ranges of 
body fat for runners, cyclist and swimmers (presented in Table 8).  No data were found for 
college-aged female cyclists.  As expected, the body fat for our elderly athletes was much higher 
for all three sports. 
 
Table 8  Body fat values for college-aged athletes compared with elderly athletes of the current study 
College-aged 
Athletes 
Runners Cyclists Swimmers 
Males 3.0 – 15.0%181 10.5 – 13.7%79, 218, 339 5.0 – 12.3%79, 218, 300 
Females 13.6 – 14.2%190 *No Data Available* 16.1 – 17.1%190, 219 
Elite Master Athletes 
from current study 
Runners Cyclists Swimmers 
Males 19.6% 22.4% 24.1% 
Females 28.9% 26.4% 34.2% 
 
 
For the purpose of this discussion, we examined the data in five year age categories.  
Unlike previous studies160, 161, we did not see a significant difference between age categories in 
either controls or athletes in the arm or leg body fat regions.  However, we did see a significant 
difference in body fat of the trunk, in controls only, between age categories.  The findings of 
these analyses are presented in the figures 10 – 12.   The graphs illustrate a slight trend in the 
controls, although not significant, of body fat percentage of the arm and leg that increases with 
age.  The control group we recruited were healthy, relatively active individuals and may not best 
represent the general population of elderly; therefore, if a more sedentary control group were 
used we may see a more significant trend.  However the significant difference for trunk body fat 
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percentage for controls and not for athletes helps to support the findings of previous studies that 
show an age-related increasing of body fat.160, 161  This finding is perhaps the most important 
considering that abdominal fat, in particular, has been linked to increased risk for multiple 
chronic disease conditions, such as heart disease and metabolic syndrome. 34, 78, 119, 279, 226, 241  
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 Figure 10 Left Arm Body Fat Percentage by Age Category 
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Figure 12  Left Leg Body Fat Percentage by Age Category 
5.2 MUSCLE MASS 
Mineral free lean mass of the arm and leg was significantly higher in both male and 
female athletes when compared to healthy controls.    This is consistent with previous studies 
that showed higher mineral free lean mass with greater physical activity. 73-75, 122, 225, 266  
Endurance type activity shows increases in cross-sectional area and resistance type activity has 
shown increases in size and number of myofibrils all leading to greater mineral free lean mass.6, 
145  In our elite athlete group, the runners and cyclists in this study were endurance athletes, 
while swimmers in any event were included in the study.  It is unknown what resistance training, 
if any, was regularly performed by our subjects. 
 
In a study by Penn et al., they found the lean muscle mass to of male distance runners 
with mean age of 27.9 to be 73.5% and the mineral-free lean mass of controls (subjects 
completed less than 4 hours of recreational activity per week) with a mean age of 27.8 to be 
72.7.217  Whereas, a study by Hetland et al. reported the mineral-free lean mass in males with a 
mean age of 32 years to be as much as 89.4% in recreational runners (mean 60 km per week), 
91.6%  in elite runners (mean 118 km per week) and 86.2%  in control subjects.217  The subjects 
from this study, as expected, had a lower percent mineral-free lean mass than that of the younger 
subjects from the Hetland study; but surprisingly, the male runners in our study had higher 
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mineral free lean percentages than that of the younger participants in the Penn study.  Because 
the subjects in the Penn study were much younger, the discrepancy in mineral free lean 
percentages may be due to maturation issues.  The results for this study are presented in table 9.   
 
  
Table 9  Mineral Free Lean Mass Percentage for Participants of the Current Study 
 Runners Cyclists Swimmers Controls 
Males 76.8% 74.5% 72.7% 71.3% 
Females 67.9% 70.5% 63.4% 53.3% 
 
 
With many complications associated with sarcopenia, many studies have also looked at 
the decrease in mineral free lean mass with age.  For the purposes of this discussion, we 
examined the data in five year age categories in relation to percent mineral free lean mass of the 
arm and leg (i.e. percent muscle).  Interestingly, there were significant differences in percentage 
of mineral free lean mass of the arm and leg between age categories of controls while there were 
no significant differences among age categories for athletes (figure 13-14).  We also found 
significant correlations between age and percentage of mineral free lean mass of the leg and arm 
in controls only.  In our review of the data it was interesting to note that we found a significant 
negative correlation between age and percent mineral free lean mass of the leg and arm only in 
the control subjects.  This indicates that the athletes do not experience the same relationship 
between age and muscle mass decline.  This leads us to speculate that indeed intense levels of 
physical activity may help combat the age-related decline in mineral free lean mass.  This is 
especially important considering that physical activity may directly or indirectly help combat a 
major cause of frailty in the elderly.   
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This study also found men had a higher percentage of mineral free lean mass than did 
women for both the arm and leg in both athletes and controls.   This is consistent with previous 
studies that found women to have less mineral free lean mass than men in both overall and 
regional measures.90, 136   
 
These findings point to the speculation that athletics and exercise play more of a role than 
genetics when it comes to the common age-related declines in muscular strength and muscle 
mass, and increases in fat mass.  If genetics were the predominant factor in these age-related 
decrements then we would see a parallel decline in muscle strength and muscle mass and a 
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parallel increase in fat mass with age in both groups.  However this is not the case, our data 
shows age-related trends in only the control subjects. 
5.3 RELATIONSHIP BETWEEN MUSCLE STRENGTH AND MINERAL FREE LEAN 
MASS 
Age-related declines in strength have been well documented in the literature, stating 
average losses between 20-40%, even upwards of 50% into the 9th decade.63, 64, 225, 317  Previous 
studies have reported a high correlation between muscle mass and muscle strength, however, 
Frontera et al. reported disproportionate gains in strength and leg muscle mass, indicating that 
other neuromuscular changes may mediate strength decreases.  In a study conducted 
simultaneously with the current investigation, McCroy et al. found a significant difference in all 
strength values between athletes and controls, however, they found no significant effect for age 
in either groups.189  Our study showed significant correlations between leg muscle mass and 
muscle strength in all samples.  Although all relationships were significant, we saw stronger 
relationships between leg muscle mass and extension torque.  This may be due to the fact that 
quadriceps are often larger in cross-sectional area because they are made up of four muscles 
whereas hamstrings have only three.   
 
When we separated the athlete and control groups, we saw stronger correlations for the 
extension values and muscle mass in the controls; however, when looking at flexion values we 
experienced stronger correlations in the athletes.  This may be due to a balanced training regimen 
focusing on the hamstrings in the athletes.   
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5.4 RELATIONSHIP BETWEEN BONE MINERAL DENISTY AND OTHER BODY 
COMPOSTION PARAMETERS 
Previous studies have indicated that bone mineral mass is closely related to other body 
composition variables.11, 48, 158, 245, 249  However, results of previous studies are not in agreement 
on whether fat tissue mass or lean tissue mass is the major determinant of bone mineral mass in 
women.11, 48, 245, 249  One study has suggested that in men the predominant relationship is with 
lean muscle mass and bone mineral density and in women, the predominant relationship is with 
fat mass and bone mineral density.249   
 
Studies have elucidated many other aspects that may be related to bone mineral density 
such as genetics, gender, race, nutritional factors, lifestyle factors, hormones, chronic diseases 
and medication as well as body composition.11, 26, 42, 59, 120, 121, 165, 169, 201, 210, 231, 236, 242, 244-246, 249, 
277, 295, 303, 305, 307, 314, 325  In the context of this dissertation, the most interesting factor when 
discussing bone mineral density and muscle mass may be physical activity.  It has been shown 
that lack of physical activity decreases bone density and that physical activity has a protective 
effect on bone mineral density. 115, 201, 231, 296, 304   
 
In our study, we examined the athletes and controls separately and then combined 
independent of gender.  We found significant relationships in all samples between bone mineral 
density of the radius and hip and mineral free lean mass of the arm and leg, showing when lean 
muscle mass increases so does bone mineral density.  Even though all relationships were 
significant, there was a stronger relationship in all samples between the bone mineral density of 
the hip and mineral free lean mass of the leg.  This may be due to the influence of mechanical 
loading on the joint.  Since weight-bearing activity has been shown to be more osteogenic than 
non weight bearing activity54, it would lead us to believe that given the loads and impact that the 
hip bears it would have higher bone mineral density.  The increase in mineral free lean mass 
would also increase the weight load on the joint contributing to the weight bearing effect.  Also, 
since increased muscle mass is associated with increased muscle strength, this would result in a 
stronger pull on the bone from the muscle attachment points, therefore increasing the load on the 
bone, resulting in more stress and further contributing to the osteogenic effects.  This 
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corroborates the 1990 study by Heinrich et al., which showed that higher muscle mass, which is 
correlated to muscular strength, and thus reflects higher contractile forces exerted on the 
skeleton, and lead to increased bone mass.117   
 
In regard to body fat, the relationships were quite different than we initially expected.  In 
all samples we found significant negative relationships between bone mineral density of the 
radius and % body fat of the arm, and bone mineral density of the hip and % body fat of the leg.  
However, no relationship was found between bone mineral density of the spine and trunk fat 
percentage. The absence of this relationship may be affected by possible measurement error due 
to the fact that the presence of large amounts of abdominal tissue could affect the accuracy of the 
findings.  In order to more accurately assess bone mineral density of the spine in subjects with a 
large abdominal mass, it may be best to use a lateral scan of the spine. These data indicate that 
lean muscle mass may be a better determinant of bone mineral density in the elderly population. 
 
The negative relationships found between regional body fat and regional bone mineral 
density is particularly interesting considering that previous studies, including the larger study of 
which this dissertation is a part, indicate that weight and BMI are strong determinants of bone 
mineral density.53, 184, 186, 187, 302  This may indicate that the weight bearing mechanical loading 
and the pull on the bone produced by the attached muscles contributes more to the bone density 
than does an individual component of body composition.  This is an area that would require 
further research in order to show a causal relationship.   
 
5.5 LIMITATIONS OF THE STUDY 
Because the data are cross-sectional, cause and effect cannot be determined.  Even 
though we excluded subjects for certain prescribed drugs and diseases that could affect bone 
density, we did not exclude for all medications that could adversely affect any other measure of 
body composition.  Therefore, factors other than aging may well have been responsible for the 
differences reported.   
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 In this study, all of the subjects were volunteers and were not recruited from the same 
geographical location.  The athletes were recruited from the 2005 National Senior Games and, 
therefore, were originally from a wide array of locations across the United States.  The control 
group was recruited from the University of Pittsburgh Claude D. Pepper Older Americans 
Independence Center, and therefore, primarily from the Pittsburgh metro area.  This could affect 
the results due to differences in climate, access to health care, quality of health care, and access 
to physical activity programs and facilities.  Also, since these subjects were all volunteers and 
were in good health, they may not be representative of the general older population.   
 
In this study, despite our best efforts, the control group was significantly older than the 
athletes.  This may serve to further exaggerate the differences found between groups.  In an 
effort to minimize the exaggeration, we did analyze and report data in separate 5 year age 
categories. 
5.6 FUTURE DIRECTIONS 
Future research is needed to further substantiate the results of this study.  In order to 
show a causal relationship between exercise and the prevention of common age-related declines 
a longitudinal study would need to be preformed.  This would help to prove the benefits of 
exercise and aging.  Also in order to determine the exact frequency, intensity and type of 
exercise needed several intervention studies would need to be performed.   
 
During the current investigation we also collected data regarding the life long activity of 
the control subjects.  This data will be used to further address the role activity plays on body 
composition components.   
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APPENDIX A – Statistical Tables 
A.1 REGIONAL MEASURES OF BODY FAT 
ANOVA % Body Fat in Left arm 
  
Tests of Between-Subjects Effects 
Dependent Variable: % Body Fat in Left arm (using total grams from DXA)  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Noncent. 
Parameter 
Observed 
Power(a) 
Corrected Model 27.479(b) 3 9.160 52.465 .000 157.394 1.000
Intercept 440.059 1 440.059 2520.586 .000 2520.586 1.000
Gender 24.685 1 24.685 141.391 .000 141.391 1.000
Group 2.999 1 2.999 17.180 .000 17.180 .985
Gender * Group .736 1 .736 4.213 .042 4.213 .532
Error 30.029 172 .175      
Total 470.591 176       
Corrected Total 57.508 175       
a  Computed using alpha = .05 
b  R Squared = .478 (Adjusted R Squared = .469) 
 
 
 
ANOVA % Body Fat in Trunk 
 
 Tests of Between-Subjects Effects 
Dependent Variable: % Body Fat in Trunk (using total grams from DXA)  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Noncent. 
Parameter 
Observed 
Power(a) 
Corrected Model 1138.070(b) 3 379.357 22.626 .000 67.879 1.000
Intercept 34445.789 1 34445.789 2054.490 .000 2054.490 1.000
Gender 658.247 1 658.247 39.261 .000 39.261 1.000
Group 495.390 1 495.390 29.547 .000 29.547 1.000
Gender * Group 54.229 1 54.229 3.234 .074 3.234 .432
Error 2883.769 172 16.766      
Total 37762.955 176       
Corrected Total 4021.839 175       
a  Computed using alpha = .05 
b  R Squared = .283 (Adjusted R Squared = .270) 
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ANOVA % Body Fat in Left Leg 
 
 Tests of Between-Subjects Effects 
Dependent Variable: % Body Fat in Left Leg (using total grams from DXA)  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Noncent. 
Parameter 
Observed 
Power(a) 
Corrected Model 377.936(b) 3 125.979 87.943 .000 263.830 1.000
Intercept 3975.433 1 3975.433 2775.172 .000 2775.172 1.000
Gender 350.021 1 350.021 244.343 .000 244.343 1.000
Group 33.383 1 33.383 23.304 .000 23.304 .998
Gender * Group 3.250 1 3.250 2.269 .134 2.269 .322
Error 242.092 169 1.432      
Total 4232.400 173       
Corrected Total 620.028 172       
a  Computed using alpha = .05 
b  R Squared = .610 (Adjusted R Squared = .603) 
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 A.2 REGIONAL MEASURES OF MINERAL FREE LEAN TISSUE 
ANOVA % Mineral Free Lean Tissue in Left Arm 
  
 
Tests of Between-Subjects Effects 
Dependent Variable: % Lean tissue in Left arm (using total grams from DXA)  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Noncent. 
Parameter 
Observed 
Power(a) 
Corrected Model 62.126(b) 3 20.709 89.943 .000 269.830 1.000
Intercept 2158.058 1 2158.058 9372.994 .000 9372.994 1.000
Gender 57.727 1 57.727 250.723 .000 250.723 1.000
Group 4.454 1 4.454 19.343 .000 19.343 .992
Gender * Group .075 1 .075 .326 .569 .326 .088
Error 39.602 172 .230      
Total 2569.710 176       
Corrected Total 101.728 175       
a  Computed using alpha = .05 
b  R Squared = .611 (Adjusted R Squared = .604) 
 
 
ANOVA % Mineral Free Lean Tissue in Left Leg 
  
Tests of Between-Subjects Effects 
Dependent Variable: % Lean tissue in Left Leg (using total grams from DXA)  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Noncent. 
Parameter 
Observed 
Power(a) 
Corrected Model 167.205(b) 3 55.735 36.976 .000 110.928 1.000
Intercept 19694.930 1 19694.930 13066.174 .000 13066.174 1.000
Gender 121.917 1 121.917 80.883 .000 80.883 1.000
Group 45.721 1 45.721 30.332 .000 30.332 1.000
Gender * Group .206 1 .206 .137 .712 .137 .066
Error 254.737 169 1.507      
Total 22375.870 173       
Corrected Total 421.942 172       
a  Computed using alpha = .05 
b  R Squared = .396 (Adjusted R Squared = .386) 
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A.3 CORRELATION TABLES FOR MINERAL FREE LEAN AND 
BMD 
Correlation for Combined Sample 
  
 
  
% Lean tissue 
in Left arm 
(using total 
grams from 
DXA) 
% Lean tissue 
in Left Leg 
(using total 
grams from 
DXA) TotalHipBMD 
TotRadiusBM
D 
% Lean tissue in Left 
arm (using total grams 
from DXA) 
Pearson Correlation 
1 .795(**) .362(**) .640(**)
  Sig. (1-tailed)  .000 .000 .000
  N 176 173 176 175
% Lean tissue in Left 
Leg (using total grams 
from DXA) 
Pearson Correlation 
.795(**) 1 .248(**) .454(**)
  Sig. (1-tailed) .000  .001 .000
  N 173 173 173 172
TotalHipBMD Pearson Correlation .362(**) .248(**) 1 .649(**)
  Sig. (1-tailed) .000 .001   .000
  N 176 173 185 184
TotRadiusBMD Pearson Correlation .640(**) .454(**) .649(**) 1
  Sig. (1-tailed) .000 .000 .000  
  N 175 172 184 184
**  Correlation is significant at the 0.01 level (1-tailed). 
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Correlation Tables for Athlete and Control Samples 
  
Athlete 
or 
Control   
% Lean 
tissue in 
Left arm 
(using 
total 
grams 
from 
DXA) 
% Lean 
tissue in 
Left Leg 
(using 
total 
grams 
from 
DXA) 
TotalHipB
MD 
TotRadius
BMD 
Athlete % Lean tissue in 
Left arm (using 
total grams from 
DXA) 
Pearson 
Correlation 1 .737(**) .277(**) .548(**) 
    Sig. (1-tailed)  .000 .004 .000 
    N 93 93 93 92 
  % Lean tissue in 
Left Leg (using 
total grams from 
DXA) 
Pearson 
Correlation .737(**) 1 .196(*) .388(**) 
    Sig. (1-tailed) .000  .030 .000 
    N 93 93 93 92 
  TotalHipBMD Pearson 
Correlation .277(**) .196(*) 1 .638(**) 
    Sig. (1-tailed) .004 .030  .000 
    N 93 93 99 98 
  TotRadiusBMD Pearson 
Correlation .548(**) .388(**) .638(**) 1 
    Sig. (1-tailed) .000 .000 .000   
    N 92 92 98 98 
Control % Lean tissue in 
Left arm (using 
total grams from 
DXA) 
Pearson 
Correlation 1 .854(**) .473(**) .745(**) 
    Sig. (1-tailed)  .000 .000 .000 
    N 83 80 83 83 
  % Lean tissue in 
Left Leg (using 
total grams from 
DXA) 
Pearson 
Correlation .854(**) 1 .375(**) .564(**) 
    Sig. (1-tailed) .000  .000 .000 
    N 80 80 80 80 
  TotalHipBMD Pearson 
Correlation .473(**) .375(**) 1 .667(**) 
    Sig. (1-tailed) .000 .000  .000 
    N 83 80 86 86 
  TotRadiusBMD Pearson 
Correlation .745(**) .564(**) .667(**) 1 
    Sig. (1-tailed) .000 .000 .000   
    N 83 80 86 86 
**  Correlation is significant at the 0.01 level (1-tailed). 
*  Correlation is significant at the 0.05 level (1-tailed). 
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A.4 CORRELATION TABLES FOR BODY FAT AND BMD 
Correlation for Combined Sample 
 Correlations 
 
  
% Body 
Fat in Left 
arm (using 
total 
grams 
from 
DXA) 
% Body 
Fat in 
Trunk 
(using 
total grams 
from 
DXA) 
% Body 
Fat in Left 
Leg (using 
total 
grams 
from 
DXA) 
Spine 
BMD 
TotalHip 
BMD 
TotRadius 
BMD 
% Body Fat in Left 
arm (using total 
grams from DXA) 
Pearson 
Correlation 1 .751(**) .778(**) -.182(**) -.290(**) -.508(**)
  Sig. (1-tailed)  .000 .000 .008 .000 .000
  N 176 176 173 175 176 175
% Body Fat in Trunk 
(using total grams 
from DXA) 
Pearson 
Correlation .751(**) 1 .633(**) .000 -.111 -.338(**)
  Sig. (1-tailed) .000  .000 .498 .071 .000
  N 176 176 173 175 176 175
% Body Fat in Left 
Leg (using total 
grams from DXA) 
Pearson 
Correlation .778(**) .633(**) 1 -.259(**) -.386(**) -.600(**)
  Sig. (1-tailed) .000 .000  .000 .000 .000
  N 
173 173 173 172 173 172
SpineBMD Pearson 
Correlation -.182(**) .000 -.259(**) 1 .663(**) .541(**)
  Sig. (1-tailed) .008 .498 .000   .000 .000
  N 175 175 172 184 184 183
TotalHipBMD Pearson 
Correlation -.290(**) -.111 -.386(**) .663(**) 1 .649(**)
  Sig. (1-tailed) .000 .071 .000 .000   .000
  N 176 176 173 184 185 184
TotRadiusBMD Pearson 
Correlation -.508(**) -.338(**) -.600(**) .541(**) .649(**) 1
  Sig. (1-tailed) .000 .000 .000 .000 .000  
  N 175 175 172 183 184 184
**  Correlation is significant at the 0.01 level (1-tailed). 
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Correlation for Athlete and Control Samples 
  
Athlete 
or 
Control   
% Body 
Fat in Left 
arm (using 
total 
grams 
from 
DXA) 
% Body 
Fat in 
Trunk 
(using 
total 
grams 
from 
DXA) 
% Body 
Fat in Left 
Leg (using 
total 
grams 
from 
DXA) 
Spine 
BMD 
TotalHip 
BMD 
TotRadius
BMD 
Athlete % Body Fat in 
Left arm (using 
total grams from 
DXA) 
Pearson 
Correlation 1 .776(**) .731(**) -.061 -.231(*) -.407(**)
    Sig. (1-tailed)  .000 .000 .283 .013 .000
    N 93 93 93 92 93 92
  % Body Fat in 
Trunk (using 
total grams from 
DXA) 
Pearson 
Correlation .776(**) 1 .588(**) .028 -.065 -.210(*)
    Sig. (1-tailed) .000  .000 .397 .266 .022
    N 93 93 93 92 93 92
  % Body Fat in 
Left Leg (using 
total grams from 
DXA) 
Pearson 
Correlation .731(**) .588(**) 1 -.195(*) -.338(**) -.514(**)
    Sig. (1-tailed) .000 .000  .031 .000 .000
    N 
93 93 93 92 93 92
  SpineBMD Pearson 
Correlation -.061 .028 -.195(*) 1 .659(**) .506(**)
    Sig. (1-tailed) .283 .397 .031   .000 .000
    N 92 92 92 98 98 97
  TotalHipBMD Pearson 
Correlation -.231(*) -.065 -.338(**) .659(**) 1 .638(**)
    Sig. (1-tailed) .013 .266 .000 .000  .000
    N 93 93 93 98 99 98
  TotRadiusBMD Pearson 
Correlation -.407(**) -.210(*) -.514(**) .506(**) .638(**) 1
    Sig. (1-tailed) .000 .022 .000 .000 .000  
    N 92 92 92 97 98 98
Control % Body Fat in 
Left arm (using 
total grams from 
DXA) 
Pearson 
Correlation 1 .703(**) .802(**) -.375(**) -.368(**) -.615(**)
    Sig. (1-tailed)  .000 .000 .000 .000 .000
    N 83 83 80 83 83 83
  % Body Fat in 
Trunk (using 
total grams from 
DXA) 
Pearson 
Correlation .703(**) 1 .637(**) -.164 -.189(*) -.486(**)
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    Sig. (1-tailed) .000  .000 .070 .043 .000
    N 83 83 80 83 83 83
  % Body Fat in 
Left Leg (using 
total grams from 
DXA) 
Pearson 
Correlation .802(**) .637(**) 1 -.421(**) -.466(**) -.697(**)
    Sig. (1-tailed) .000 .000  .000 .000 .000
    N 
80 80 80 80 80 80
  SpineBMD Pearson 
Correlation -.375(**) -.164 -.421(**) 1 .674(**) .619(**)
    Sig. (1-tailed) .000 .070 .000   .000 .000
    N 83 83 80 86 86 86
  TotalHipBMD Pearson 
Correlation -.368(**) -.189(*) -.466(**) .674(**) 1 .667(**)
    Sig. (1-tailed) .000 .043 .000 .000  .000
    N 83 83 80 86 86 86
  TotRadiusBMD Pearson 
Correlation -.615(**) -.486(**) -.697(**) .619(**) .667(**) 1
    Sig. (1-tailed) .000 .000 .000 .000 .000  
    N 83 83 80 86 86 86
**  Correlation is significant at the 0.01 level (1-tailed). 
*  Correlation is significant at the 0.05 level (1-tailed). 
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APPENDIX B – Informed Consent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78 
CONSENT TO ACT AS A PARTICIPANT IN A RESEARCH STUDY 
 
TITLE:   The Effect of High Impact Exercise on Skeletal Integrity in Master Athletes  
 
 
PRINCIPAL INVESTIGATOR:   
 
 Susan L. Greenspan, MD 
 Professor of Medicine 
 Director, Osteoporosis Prevention and Treatment Center 
 University of Pittsburgh Medical Center 
 1110 Kaufmann Building 
 3471 Fifth Avenue 
 Pittsburgh, PA  15213 
 (412) 692-2476 (direct) 
(412) 692-2220 (reception) 
 
 
CO-INVESTIGATORS: 
  
 Jean McCrory, PhD 
 Assistant Professor 
 Greg Norman Associate Director of the NMRL 
 Department of Sports Medicine and Nutrition 
 School of Health and Rehabilitation Sciences 
 University of Pittsburgh 
 Neuromuscular Research Laboratory 
 UPMC Center for Sports Medicine 
 3200 S. Water St. 
 Pittsburgh, PA  15203 
 412-432-3618 
 79 
  
Megan Miller, BS, CCRC 
Clinical Research Coordinator 
University of Pittsburgh Medical Center 
 Osteoporosis Prevention & Treatment Center 
 1110 Kaufmann Medical Building 
 3471 Fifth Avenue 
Pittsburgh, PA 15213 
412-692-2477 (direct) 
412-692-2220 (reception) 
412-958-6557 (pager for study-related emergencies) 
 
Julie Wagner, PA-C, MPA 
 Clinical Support 
 University of Pittsburgh Medical Center 
 Osteoporosis Prevention & Treatment Center 
1110 Kaufmann Medical Building 
 3471 Fifth Avenue 
 Pittsburgh, PA 15213 
412-692-2478 
 
Karen Vujevich, MSN, CRNP 
 Clinical Support 
 University of Pittsburgh Medical Center 
 Osteoporosis Prevention & Treatment Center 
 1110 Kaufmann Medical Building 
 3471 Fifth Avenue 
 Pittsburgh, PA 15213 
 412-692-2479 (direct) 
 
  
 80 
Matthew Levy, MD 
 Endocrine Research Fellow 
 University of Pittsburgh Medical Center 
 Osteoporosis Prevention & Treatment Center 
 1110 Kaufmann Medical Building 
 3471 Fifth Avenue 
 Pittsburgh, PA 15213 
 412-692-2475 (direct) 
 
 Parmatma Greeley 
Endocrine Research Fellow 
 University of Pittsburgh Medical Center 
 Osteoporosis Prevention & Treatment Center 
 1110 Kaufmann Medical Building 
 3471 Fifth Avenue 
 Pittsburgh, PA 15213 
 412-692-2481 (direct) 
 
 
 
SOURCE(S) OF SUPPORT:  
Aventis/Procter & Gamble Pharmaceuticals (Alliance for Better Bone Health) 
Osteoporosis Prevention and Treatment Center 
Gift Fund (Private Donor Bequest)  
 
 
 
 
 
 
 
 81 
Why is this research being done? 
 
The purpose of this research study is to see if high-impact sports (running) in master 
athletes will produce greater bone mass in the spine, hip, and heel than medium-impact sports 
(cycling) or low-impact sports (swimming), and to see how that compares with bone mass in 
men and women of similar age who are not master athletes. Bone mass (also known as bone 
density) is a measure of bone strength. 
 
 
Who is being asked to take part in this research study? 
 
You are being asked to participate in this study because you are a senior master athlete 
participating in one of these sports, or a non-athlete age 65 or older living in the Pittsburgh area.  
Up to 600 subjects will be screened in order to find 230 eligible male and female participants 
ages 65 and older who are either master athletes or community dwelling non-athletes.  
 
 
What procedures will be performed for research purposes? 
 
If you decide to take part in this research study, you will undergo the following 
procedures that are not part of your standard medical care: 
 
Screening Procedures: Procedure to determine if you are eligible to take part in a research 
study are called “screening procedures.” For this research study, the screening procedures will 
include: 
 1. Questions about your health, medications, age, demographics, and 
exercise/sports category (impact level and Senior Olympic competition event). These questions 
will take about 5-10 minutes and will be done immediately following the informed consent 
process or by telephone screening. 
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If you qualify to take part in this research study you will be scheduled for an appointment 
for the remaining tests, which will be performed at the General Clinical Research Center 
(GCRC) at Montefiore Hospital at the University of Pittsburgh Medical Center (UPMC) and will 
involve one study visit which will take approximately 2-3 hours of your time. 
  
Study Procedures: The following study procedures will be attempted at your GCRC visit 
(approx. 2-3 hours): 
1. A nurse practitioner, physician assistant, registered nurse, or phlebotomist will draw 
blood upon your arrival to determine your indicators of bone change, bone mineral 
metabolism and for general health measures (takes less than 5 minutes). 
2. Dual-energy X-ray absorptiometry (DXA) of the hip, spine, forearm, and total body. You 
will be asked to lie still on a padded table for approximately 20 minutes while the arm of 
the DXA machine (a special low-radiation X-ray machine) passes over those body 
regions to measure the thickness of your bones and your body composition. 
3. A urine sample will be taken for markers of bone turnover (takes less than 5 minutes). 
Bone is in a constant state of change as new bone is made and old bone is broken down. 
We can measure this turnover indirectly by measuring the protein breakdown products of 
bone in urine. 
4. Height and weight (takes less than 5 minutes) 
5. Food Frequency (dietary calcium intake) Questionnaire (approx. 20 minutes) 
6. Quality of Life Questionnaire (approx. 10 minutes) 
8. Heel ultrasound, a procedure which measures bone thickness by sound waves. For this 
procedure, you will be asked to remove your shoes and socks and roll up one pant leg. 
The technologist will apply clear gel to each side of your heel and place your foot in the 
unit, which sits on the floor. When the technologist starts the test, sound waves will move 
through your heel, measuring the thickness of the bone. This procedure requires a few 
minutes. Afterward, the gel will be wiped from your heel and the machine will be cleaned 
thoroughly. This procedure takes less than 5 minutes. 
9. Strength Test: You will be asked to sit in the chair used with the strength measurement 
device so that we may secure your body with cloth straps to eliminate any unnecessary 
motion. We will secure your left leg to the device using a cloth strap. You will extend 
your left leg as hard as you can for five seconds, immediately after which you will rest 
for thirty seconds then repeat this action three times. You will then be asked to bend your 
knee at your maximal effort level. Again, you will perform three five-second contractions 
with thirty seconds of rest between each. You will be instructed to keep breathing during 
the test and to not hold your breath. No encouragement or coaching will be given during 
the test, only reminders to keep breathing. You will also be able to stop the test at any 
time if you feel you can’t continue. This procedure takes less than 10 minutes. 
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10. Injury and Fitness/Leisure Activity Questionnaire: Following the strength testing, you 
will be asked questions about any major or recent musculoskeletal injuries and about 
your participation in physical activities over the last year and during previous stages of 
your life. This questionnaire will take approximately 10-15 minutes to complete.  
 
 
What are the possible risks, side effects, and discomforts of this research study? 
 
Risks of the Blood Tests 
Some common risks may include pain, bleeding, and the possibility of bruising at the site 
of the blood draw or the feeling of lightheadedness (occurs in 1-25%, or 1-25 people out of 100), 
and rarely, infection at the site of the blood draw (occurs in less than 1%, or less than 1 out of 
100 people).  A maximum of up to 70 ml (approximately 14 teaspoons) of blood will be drawn 
for the study procedures listed above.  
 
Risks of Radiation Exposure 
Participation in this research study will involve exposure to radiation from the DXA 
studies (spine, hip, wrist and whole body). If the research subject completes all of these studies, 
as outlined in this protocol, the total radiation dose to your spine will be about 10 mrems (a 
mrem is a unit of radiation dose); to your hip will be about 10 mrems; and to your wrist will be 
about 5 mrems. The whole body DXA scan will result in a whole body radiation dose of about 1 
mrem. For comparison, these radiation doses are a very small fraction of the maximum annual 
single organ radiation dose (50,000 mrems) and maximum annual whole body radiation dose 
(5000 mrems) permitted by Federal regulation to adult radiation workers. There is no minimum 
level of radiation exposure that is recognized as being totally free of the risk of causing genetic 
mutations (abnormal cells) or cancer. However, the risk associated with the amount of radiation 
exposure research subjects will receive from participation in this research study is considered to 
be low and comparable to everyday risks. 
 
Heel Ultrasound 
There is no known risk from ultrasound testing. 
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Strength Testing 
We do not anticipate any injuries and the risks of participation are small. However, it is 
possible as with any experiment that harmful effects may occur. If an injury does occur, the 
investigators listed on the front page of this form will administer immediate and appropriate first 
aid care. 
 Because this is a muscle contracting exercise, the occurrence of slight muscle 
soreness is possible. This mild soreness typically develops 2-3 days after the experiment and 
may last approximately 2-3 days.  
 
 
What are possible benefits from taking part in this study? 
 
There may be no direct benefit to your participation in this study. This study is being 
performed to advance medical knowledge in general and is not specifically intended to diagnose 
or treat any illness you may have. However, one benefit is that you will learn your bone mineral 
density.  
 
 
What treatments or procedures are available if I decide not to take part in this research study? 
 
DXA scans of various body regions (e.g., the spine, hip, wrist) are available outside of 
study participation for the diagnosis and evaluation of osteopenia/osteoporosis (thinning and 
weakening of bones). You may choose not to participate and discuss how to get a DXA scan 
with your physician.  
 
 
Will my insurance provider or I be charged for the cost of any procedures performed as part of 
this research study? 
 
Neither you nor your insurer will be billed for study procedures. The study procedures (DXA, 
blood and urine tests, heel ultrasound, questionnaires, strength testing) will be paid for by the 
study sponsor. 
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Will I be paid if I take part in this research study? 
 
You will be provided with a parking sticker for Montefiore Hospital. 
 
 
Who will pay if I am injured as a result of taking part in this study? 
 
University of Pittsburgh researchers and their associates who provide services at UPMC 
recognize the importance of your voluntary participation in their research studies. These 
individuals and their staffs will make reasonable effort to minimize, control, and treat any 
injuries that may arise as a result of this research. If you believe that you are injured as a result of 
the research procedures being performed, please contact immediately the Principal Investigator 
or one of the co-investigators listed on the first page of this form. Emergency medical treatment 
for injuries solely and directly related to your participation in this research study will be provided 
to you by the hospitals of UPMC. It is possible that UPMC may bill your insurance provider for 
the costs of this emergency treatment, but none of these costs will be charged directly to you. If 
your research-related injury requires medical care beyond this emergency treatment, you will be 
responsible for the costs of this follow-up care unless otherwise specifically stated below. There 
is no plan for monetary compensation. You do not, however, waive any legal rights by signing 
this form. 
 
Who will know about my participation in this research study? 
 
This research study will result in identifiable information that will be placed into your 
medical records held at the Osteoporosis Prevention and Treatment Center under lock and key.  
The nature of the identifiable information resulting from your participation in this research study 
that will be recorded in your medical record includes DXA scan reports, brief history per 
screening/eligibility questions, medications, lab values, heel ultrasound results, and progress 
notes which were performed for research purposes and information related to any adverse events 
you may experience related to the study procedures.  
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This research study will result in identifiable information that will be placed into your 
medical records held at UPMC Presbyterian [Medical  ARchival System (MARS)]. The nature of 
the identifiable information resulting from your participation in this research study that will be 
recorded in MARS includes lab values and information related to any adverse events you may 
experience related to the study procedures. 
 
 
Who will have access to identifiable information related to my participation in this research 
study? 
 
In addition to the investigators listed on the first page of this authorization (consent) form 
and their research staff, the following individuals will or may have access to identifiable 
information, which may include your identifiable medical information, related to your 
participation in this research study: 
 
Authorized representatives of the University of Pittsburgh Research Conduct and 
Compliance Office may review your identifiable research information, which may 
include your identifiable medical information, for the purpose of monitoring the 
appropriate conduct of this research study. 
 
In unusual cases, the investigators may be required to release identifiable 
information, which may include your identifiable medical information, related to your 
participation in this research study in response to an order from a court of law. If the 
investigators learn that you or someone with whom you are involved is in serious danger 
or potential harm, they will need to inform, as required by Pennsylvania law, the 
appropriate agencies. 
 
Authorized representatives of the UPMC hospitals and affiliated health care 
providers may have access to identifiable information, which may include your 
identifiable medical information, related to your participation in this research study for 
the purpose of (1) fulfilling orders, made by the investigators, for hospital and health care 
services (e.g., laboratory tests, diagnostic procedures) associated with research study 
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participation; (2) addressing correct payment for tests and procedures ordered by the 
investigators; and/or (3) for internal hospital operations (i.e. quality assurance). 
 
 
For how long will the investigators be permitted to use and disclose identifiable information 
related to my participation in this research study? 
 
The investigators may continue to use and disclose, for the purposes described above, 
identifiable information (which may include your identifiable medical information) related to 
your participation in this research study for a minimum of five years after final reporting or 
publication of a project. 
 
 
May I have access to my medical information that results from my participation in this 
research study? 
 
In accordance with the UPMC Notices of Privacy Practices document that you have been 
provided, you are permitted access to information (including information resulting from your 
participation in this research study) contained within your medical records filed with your health 
care provider. 
 
 
Is my participation in this research study voluntary? 
 
Your participation in this research study, to include the use and disclosure of your 
identifiable information for the purposes described above, is completely voluntary. Note, 
however, that if you do not provide your consent for the use and disclosure of your identifiable 
information for the purposes described above, you will not be allowed to participate in the 
research study. Whether or not your provide your consent for participation in this research study 
will have no effect on your current or future relationship with the University of Pittsburgh. 
Whether or not you provide your consent for participation in this research study will have no 
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effect on your current or future medical care at a UPMC hospital of affiliated health care 
provider or your current or future relationship with a health care insurance provider. 
 
 
May I withdraw, at a future date, my consent for participation in this research study? 
 
You may withdraw, at any time, your consent for participation in this research study, to 
include the use and disclosure of your identifiable information for the purposes described above. 
Note, however, that if you withdraw your consent for the use and disclosure of your identifiable 
medical record information for the purposes described above, you will also be withdrawn, in 
general, from further participation in this research study. Any identifiable research or medical 
information recorded for, or resulting from, your participation in this research study prior to the 
date that you formally withdrew your consent may continue to be used and disclosed by the 
investigators for the purposes described above. 
 
To formally withdraw your consent for participation in this research study you should 
provide a written and dated notice of this decision to the principal investigator of this research 
study at the address listed on the first page of this form. 
 
Your decision to withdraw your consent for participation in this research study will have 
no effect on your current or future relationship with the University of Pittsburgh. Your decision 
to withdraw your consent for participation in this research study will have no effect on your 
current or future medical care at a UPMC hospital or affiliated health care provider or your 
current or future relationship with a health care insurance provider. 
 
 
If I agree to take part in this research study, can I be removed from the study without my 
consent? 
 
You should also be aware that you may be asked to leave the research study by the study 
doctor or sponsors, without your consent if you need other treatment, if you do not follow the 
investigators’ instructions, if you have a study-related injury, or for another reason. You might 
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also be removed for the study for other medical or administrative reasons (e.g., because the 
research is not found to be beneficial or the study resources are no longer available). We will 
notify you should this arise and advise you of available alternatives that may be of benefit at the 
time. 
 
If you leave the study, the doctor may ask to examine you and do some final tests. This 
could be important for your safety if you withdraw because of adverse effects. 
 
 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
 
VOLUNTARY CONSENT 
 
All of the above had been explained to me and all of my current questions have been 
answered. I understand that I am encouraged to ask questions about any aspect of this research 
study during the course of this study, and that such future questions will be answered by the 
researchers listed on the first page of this form.  
 
Any questions which I have about my rights as a research participant will be answered by 
the Human Subject Protection Advocate of the IRB Office, University of Pittsburgh (1-866-212-
2668). 
 
By signing this form, I agree to participate in this research study. A copy of this consent 
form will be given to me. 
 
I agree to be contacted in the future about new studies related to bone health (Check and 
initial your answer on the appropriate line below): 
YES _______   NO_______ 
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____________________________________________  ________________ 
Participant’s Signature      Date 
 
 
 
 
CERTIFICATION OF INFORMED CONSENT 
 
_____________________________________  _____________________ 
Printed Name of Person Obtaining Consent   Role in Research Study 
 
_____________________________________  ____________________ 
Signature of Person Obtaining Consent    Date 
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 * * * * * * * * * * * * * * * * * * * * * * 
 
GENETIC ASSESSMENT ADDENDUM 
 
In addition to the other blood tests for this study, we would also like to draw an additional 
10 ml sample (approx. 2 teaspoons) for genetic testing. We will examine the DNA 
(deoxyribonucleic acid) from the sample to study the genes that are thought to influence bone 
strength and density (also known as bone mass) and bone mineral metabolism (the process by 
which new bone is made and old bone is broken down, as bone is in a constant state of change). 
The goal of these exploratory research studies is to find genetic markers (genes associated with a 
particular trait) that will identify persons at high risk of low bone mass or osteoporosis (very low 
bone mass). We will test to see if there are any differences in two particular genes, the vitamin D 
receptor gene and the androgen receptor gene, which have both been shown to be involved in 
bone metabolism. 
 
The use of your sample will be confined to research focused on the study of genes related 
to osteoporosis, low bone mass or bone related changes. The factors that we are looking at will 
be examined as a group and will not be examined as individual subjects. 
 
The frozen samples are stored in a locked storage room at Montefiore Hospital, and the 
principal investigator assume overall responsibility for the control of this storage area, which is 
monitored by a security alarm service. The information linking the assigned code numbers for 
the stores samples to the corresponding subjects’ identities will be kept in a separate secure area 
at the Osteoporosis Prevention and Treatment Center. Samples, with the assigned codes but not 
the associated subject information, will be sent to Dr. Ferrell’s Laboratory in the Department of 
Human Genetics at the University of Pittsburgh for assay. 
 
Results of these studies are for research purposes only and since they are not expected to 
benefit you directly or to alter your treatment course, these results will not be placed in your 
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medical record database and will not be made available to you, members of your family, your 
personal physician, or other third parties except as specified below. 
 
Study Procedures: An additional 10 ml blood sample will be drawn at the time of your 
GCRC visit for this genetic testing at the same time the blood is drawn for the main study on the 
Effect of High Impact Exercise on Skeletal Integrity in Master Athletes.  
 
 
RISKS 
 
Two teaspoons of blood will be drawn for DNA analysis. Some common risks may 
include pain, bleeding, and the possibility of bruising at the site of the blood draw or the feeling 
of lightheadedness (occurs in 1-25%, or 1-25 people out of 100), and rarely, infection at the site 
of the blood draw (occurs in less than 1%, or less than 1 out of 100 people).  The risk of DNA 
testing is the possibility of a loss of confidentiality. The DNA tests that will be done on your 
sample have no known relationship to health. Knowledge of your genetic research data could 
potentially impact your future insurability, employability, or reproduction plans; or have a 
negative impact on family relationships; and/or result in shame or embarrassment. 
 
 
BENEFITS 
 
There will be no direct benefit to you from the analysis of these samples. Indirect benefits 
may include the possible advancement of medical knowledge so scientists can find more 
effective and safer treatments for osteoporosis. A future benefit might be helping to discover new 
treatments that will supplement currently available treatments. 
 
 
 
NEW INFORMATION 
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You will be promptly notified if any new information develops during the conduct of this 
research study that may cause you to change your mind about continuing to participate. 
 
 
COSTS AND PAYMENTS 
 
Neither you nor your insurer will be billed for the genetic testing. This study procedure 
will be paid for by the study sponsor(s). 
 
 
 
 
 
 
 
 
* * * * * * * * * * * * * * * * * * * * *  
 
VOLUNTARY CONSENT FOR GENETIC TESTING 
 
I agree to have blood drawn and stored as described above for genetic testing (Check and 
initial your answer on the appropriate line below) 
 
 YES _______   NO_______ 
 
 
 I understand that if I decline to have this blood testing performed, I can still participate in 
the main research study on the Effect of High Impact Exercise on Skeletal Integrity in Master 
Athletes. I agree that authorized persons may have access to my personal medical records, 
provided that confidentiality on the information is maintained.  
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By signing this form, I agree to participate in the genotype testing. A copy of this consent 
form will be given to me. 
 
 
_____________________________________  ____________________ 
Participant’s Signature     Date 
 
 
CERTIFICATION OF INFORMED CONSENT 
 
I certify that I have explained the nature and purpose, the potential benefits, and possible 
risks associated with participation in this research study to the above individual. Any questions 
the individual has about this study have been answered, and we will always be available to 
address future questions as they arise. 
 
 
____________________________________  __________________ 
Printed Name of Person Obtaining Consent   Role in Research Study 
 
 
____________________________________  ___________________ 
Signature of Person Obtaining Consent   Date 
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